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Abstract 
The mechanism by which retroviruses preferential ly encapsidate their unspliced 
genomic RNA among mi lLions of both spliced viral and cellular mRNAs in the cytoplasm 
represents a function of great speci fici ty. This selection process requires that the 
genomic RNA contain packaging determinants unique to its own RNA that can interact 
specifica l ly  with the packaging proteins of the viral partic les, the Gag polyproteins. 
KnO\ ing the exact sequences involved in packaging should provide basic insights into 
the mechanism of preferential ly  encapsidating the ful l  length genomic RNA. 
We have been interested in mapping the packaging determinants of the fel ine 
immunodeficiency irus (FrY), a lentivirus that is being considered as a potenti a l ly 
powerful gene delivery system for human gene therapy. Our ini t ia l  studies have shown 
that the FlY packaging detemunants are located as two discontinuous core regions witmn 
the 5 '  end of the viral genome ( Browning et a l .  2003 a & b). The first region extends 
from the RIU 5 in the 5 '  L TR to the first 120 bp of 5 '  UTR and the second consists of the 
first 1 00 bp of gag, while other regions of the genome ma y also be involved. 
Studies undertaken in this thesis carried these observations further to detemline 
whether the region in between the two core determinants was important for packaging or 
merely  acted to maintain the spacing of the hvo core elements. Additional ly, since other 
regions of the genome, especial ly  the LTR, had been implicated as containing significant 
packaging determinants in other studies ( Kemler et al . , 2002), we dissected the role  of the 
LTR elements away from the untranslated region towards FIV RNA packaging. Towards 
this end several series of smal l  FrY transfer vectors were constructed either in the 
heterologous non-viral or homologous subgenomic context containing various 
combinations of  the L TR, and/or UTR and gag and tested for their packaging potential in 
our wel l -establ ished in I'h'o packaging assay. This was fol lowed by analysis of the 
amount of transfer vector RNAs packaged direct ly into the virus partic les using a semi­
quantitative RT-PCR approach. 
Test of the \'arious transfer vector RNAs confim1ed our earl ier observation that 
the FlV packaging detenllinants are indeed discontinuous and spread out with the core 
packaging detenninants residing within the first 1 50 bp UTR and 1 00 bp of gag (Chapter 
I I I) .  Furthermore, the intervening sequences between these two elements were not 
required either for vector RNA packaging or propagation (Chapter I I I) .  Analysis of the 
L TR elements re ealed the presence of other packaging detelminants of lesser strength 
than the core detemunants in the 5' RJU5 and 3 U31R regions of the viral L TRs (Chapter 
IV). Folding of the S 'end of the viral RNA using computer analysis software revealed the 
presence of complex stem loop structures. Con-elation of the mutational analysis with the 
folding algorithms revealed the presence of a conserved stem loop in the 5 ' UTR that may 
ser\'e as the principal packaging detemunant of FlY.  Interestingly, no consistent 
structural element could be ident ified with in the first 1 00 bp of gag that could be 
responsible for the packaging potential of the gag region, suggesting that gag sequences 
may function at the primary sequence level ,  perhaps providing the intronic sequences 
needed to distinguish between genomic and subgenomic mRNAs. Taken together, these 
data should add to the increasing knowledge of how complex retroviruses package their 
genonUc RNAs and help streamline the design of safer sel f-inactivating FIV -based 
vectors for human gene therapy. 
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The technological revolution in molecular biology has brought about new ways of 
control l ing human diseases such as gene therapy. Using genes to treat, prevent and 
control  human diseases has improved the field of biomedical research and could further 
enhance the quaJ i  (y of rni l l ions of ] i es. Retroviruses are a special type of viruses that 
have proven to be ideal for human therapy due to their abi l i ty to integrate and stably 
transmit the desi red genetic material to the treated cel ls .  
In addition to medic ine, the study of retroviruses has had a great impact on other 
areas of biology, especia l ly  on molecular genetics, on the study of cel lular growth control 
and carcinogenesis, and overal l, on b iotechnology (Varrnus 1 988;  Tenlin, 1 992) .  The 
fanli l y  Retrol'iridae includes a wide vaIiety of disease-producing animal viruses that 
contain RNA as their genetic material in the virus partic le and DNA as their genetic 
material in cel ls .  Hence, this is the first example of a "reverse" flow of information from 
RNA to D A, challenging the central dogma of biology. This is due to the presence of 
"reverse transcriptase' an enzyme whose main role is  to convert the genonlic RNA into 
D A .  Because of this reversal of  infonnation, these v iruses are cal led "retro". Al l 
retroviruses and their relatives are obligatory parasites (reviewed in Vogt, 1 997) . 
Structure 
All  retroviruses have a s imil ar structure, a l thougb they cause different diseases ( Fig 1 . 1 ) . 
Starting from outside, the viTal envelope is fonned from the host cel l  membrane and 









Figure I. 1. Structure of a typical retrovi rus. The RNA is shown in the center 
of the capsid (CA) in association with the nucleocapsid prote ins (NC). The 
i ntegrase (IN), re erse transcriptase ( RT), and the protease (PR) enzymes 
are found within  the capsid forming the i nner core of the v irus. Both the 
transmembrane (TM) and the surface (SU) envelope glycoproteins are found 
with in the host cel l membrane that is attached to the core via the matrix 
(MA) proteins. 
[adapted from Retroviruses, 1 997] 
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to the surface protein ( U) .  The envelope proteins are responsible for the infectious 
properties of the retroviruses and without them the virus cannot enter the host cel l .  In 
addition, the virus membrane contains most of the host proteins, revealing that virus 
membrane comes from the host cell dUling maturation. One of the pecul iar feature of 
retrovimses is the presence of a core composed of  the capsid protein and contain ing the 
genomic RN that di ffers in i ts shape among different types of retro i ruses. The capsid 
is  held together to the membrane by the matrix protein. The presence of  two identical 
positive single-strands of RNA makes retroviruses diploid, which is not the case in other 
viruses. The RNA molecules are strongly attached to the nucleocapsid protein. The core 
also contains a l l  the enzymes required for the l i fe cycle of the virus, including the reverse 
transcriptase, integrase, and protease (reviewed in Vogt 1 997).  
Retroviral Genome 
Retroyiruses are broadly divided into two categories - simple and complex- based on the 
organization of their genomes (Coffm, 1 992a; Murphy et a1 . ,  1 994) ( Fig. 1 . 2 ) .  Whi le  
simple retroviruses contain on ly the structural genes necessary for virus particle  
fom1ation complex ones contain additional genes that give them further capab i lities to 
exploit the host cel l ul ar machinery. 
A l l  retroviruses include three to four structural genes containing the infonnation 
needed for the formation of new viral  partic les. The gag gene is responsible for the 
synthesis of structural proteins which differentiates into the matrix ( MA),  the capsid (CA) 
and the nucleocapsid (NC) proteins. The pro encodes for the protease enzyme ( PR) that 
cleaves the viral polyproteins (reviewed in Vogt, 1 997) .  
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S i mple Retrovi r u s  
Complex Ret rovi r u s  
Coding sequences 
pol 
0- tat --0 
D- rev --0 
env 
Figure 1.2. Schemanc representation of simple and complex retrovi ruses. Genes which  are common to al l  
retrO\iruses inc lude gag, pro, pol. and en\'. Complex retrovi ruses include addit ional genes such as vif. vpr. 
"pll. !lei tat. alld rev. The non-coding sequences i nclude the long term inal repeat (LTR) which contains the 
03, R, and 5. 
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The pol encodes for enzymes critical for virus repl ication, including the reverse 
transcriptase ( RT) and integrase (rN) enzymes. Finally, the product of the env gene is  
responsible for the infection of cel l s, forming the surface ( S U) and transmembrane (TM) 
components of the en e lope protein. The complex retro iruses include some additional 
genes such as tal, rev, 1'if. 1'P", )'PII, or /Ie! Some of these are critical for virus replication, 
such as tat \ hich affects the level of transcription and the elongation of  lentiviral RNAs 
(reviewed in Goff, 200 1 ) and reI', which interacts with the Rev Responsive Element 
(RRE) found in the unspl iced and singly spl iced retroviral mRNAs to faci l itate their 
nucleocytoplasmic transport without degradation (reviewed in Goff, 200 1 ) . 
Classifica t io n 
Retroviruses can be c lassified into four types based on their appearance under the 
microscope ( reviewed in Goff, 200 1 ) . The shape and position of nuc leocapsid core was 
used primari ly  as a c lassifying feature for the di fferent genera of retroviruses. Type A are 
incomplete virions since they do not have an extracel l ular phase in  their l i fe cycle .  That is  
why they are cal led "retrotransposons". Type B are assembled by budding and get 
matured with a condensed non-central core. Type C are represented in mammal ian and 
avian groups and differ from the previous types in that they mature into a condensed 
central fOlID. Fina l ly, type D partic les are very similar to type B in assembly  and budding. 
The above c lassification has been part ia l ly useful in defining retroviruses. 
However, a new c lassification was made to differentiate between the different genera of 
retroviruses (Goff, 200 1 ) . The new c lassification defines seven groups of retroviruses 
(Table 1 . 1 ) . 
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Table 1.1 : Retrovi rus genera accord i n g  to the  new class ification 
New n a me E x a mpJes M o rphology 
Alpharetrovirus, a Avian leukosis virus (ALV) C- type 
Rous sarcoma irus RSV) 
Betaretrovirus, i3 Mouse mammary tumor virus (MMTV) B-, D-type 
Mason-Pfizer monkey virus (MPMV) 
Jaagsiekte sheep retrovirus (JSRV) 
Gammaretrovirus, Y Murine leukemia viruses ( MuLV) C-type 
Feline leukemia virus ( FeLV) 
Gibbon ape leukemia virus (GaLV) 
Reticuloendothel iosis virus ( Revt) 
Deltaretrovirus, 8 H uman T-lymphotropic virus (HTLV)- l ,  -2 -
Bovine l eukemia irus ( B LV) 
Simian T-lymphotropic v irus (STLV)- l ,  -2, -3 
Epsilonretrovirus, E Wal leye dermal sarcoma virus -
Wal leye epidermal hyperplasia virus 1 
Lentivirus H uman lnmmnodeficiency virus type 1 ( H IV - 1 )  Rod/cone core 
H IV-2 
Simi an immunodeficiency virus (SIV) 
Equine infectious anemia virus ( E IA V) 
Fel ine immunodefic iency virus (F IV)  
Caprine arthrit is encephal itis virus (CAEV) 
Visnalmaedi virus 
Spumavirus Human foamy virus (HFV) Immature 
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Alpharetroviruses are s imple retroviruses having a C-type morphology. The best known 
exampJe of this group is A ian Leukemia Viruses (AL V). Betaretro iruses are also 
simple retroviruses having ei ther a B-type morphology with an eccentric core or D-type 
morphology with a cylindrical core. Mouse Mammary Tumor Virus (MMTV) and 
Mason-Pfizer Monkey Virus (MPMV) exempl ify this group. Gammaretroviruses are 
simple retroviruses characterized by a C-type morphology. This group has a wide variety 
of members, inc luding the murine and fel ine leukemia viruses ( MuLVs and FeLVs) .  
Deltaretroviruses are complex retroviruses having a C-type morphology. They are 
exemplified by the human T-Iymphotropic virus (HTLV) and the bovine leukemia 
viruses (BL V).  HTL V - 1  and 2 are an important category of retroviruses with oncogenic 
properties in humans. Epsilonretroviruses are complex viruses characterized by a C-type 
morphology. The prototype of  this group is the walleye dennal sarcoma virus (WDSV). 
Lentiviruses are complex viruses having a unique morphology with a core that is either 
cylindrical or conical in shape. One of the best known examples of this group are the 
human immunodeficiency virus types 1 and 2 ( H IV - 1  and 2 ). This category causes 
neurological and immunological diseases such as acquired immunodeficiency syndrome 
(AIDS) .  Spumaviruses are complex viruses having a unique morphological feature. They 
contain spikes on the surface and have a central uncondensed core. The prototype of this 
group is the human foamy virus ( H FV )  (reviewed in Goff, 200 1 ). 
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Retrovirus Replication 
The mechanism by which retrovi ruses repl icate is one of  the most characteristic features 
that di fferenti ates retrovi ruses from other viral famil ies. The repl ication of retroviruses 
includes two phases: the first phase includes the entry of the irus into the cel l ,  reverse 
transcription, and integration into the host genome. Al l  the processes of the first phase 
ut i l ize v iral proteins. The second phase includes transcription, translation, assembly, and 
budding; these steps util ize host cel l machinery. Briefly: 
A. Atta c h me n t  a n d  E ntry 
The first important phase of repl ication is the attachment and entry of the vi rus into the 
host cel l  ( Fig 1 . 3 ) .  Attaclunent takes place through the SU portion of the virus envelope, 
which b inds to the protein receptor found on the surface of the cel l .  In the case of H IV 
the virus infects the cel l s  of  the immune system, which are responsible for protecting the 
body from the invasion by other enemies v ia  the CD4 receptor (Clapham et a1 . ,  1 999). In 
addition to the receptor, entry of the virus into the host cel l  also requires special  co­
receptors, the chemokine receptors. When the virus b inds to the co-receptor, it activates 
and enhances the TM portion of the virus envelope to start the fusion process between the 
virus and the host cel l membranes (Berger, et a l . ,  1 999). Mutations or deletions in the co­
receptor genes may lead to a decrease in the permissibi l i ty to entry so that the virus may 
not be able to enter the cel l .  
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Figure 1.3. Retroviral rep l ication cycle .  The repl ication cycl e  starts with the 
attachment of the v irus to the receptor and entering the cel l .  Reverse transcription 
generates a double stranded DNA cal led the provi rus, which i s  then transported to 
the nucleus and integrated into the chromosomal DNA. The v i ral RNA is then 
transcribed, and either spl iced or l eaves the nucleus unspliced. Translation and 
assembly takes p lace in the cytopl asm. The v i ral RNA gets packaged i nto the v i rus 
partic les and the v i rus is released by budding and matures to fonn infectious v i rus. 
[adapted from Browning, 2001] 
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B. Rever e Tran cri pt ion 
A critical part of the retroviral repl ication is the reverse transcript ion and integration of 
the \ i rus genome into the host cel l which is a lso a pecul iar property of the retro i ruses. 
Reverse transcription usual ly begins after the entry of the virus core into the cytoplasm. 
Unl ike a l l  other viruses, once the viral RNA enters the cel l it is transcribed into DNA 
with the aid of the reverse transcriptase enzyme CRT) contained in the virus nucleocapsid 
(reviewed in Telesnitsky & Goff, 1 997) .  This l inear molecule of double-stranded D A i s  
cal led a pro irus. 
teps involyed in  the reverse transcription of retroviruses ( Fig. 1 .4 ) :  
1 .  The process of reverse transcription begins when the primer tRNA binds to the 
vira l  RNA at a complementary sequence cal led primer-binding site (Pbs) . After 
that the tRNA uses the plus strand RNA to fonn the minus strand strong stop 
D A (-sssD A) towards the 5' end and generate US and R sequences with the 
tRNA sti l l  attached to the 5 '  end. 
2. The next step involves a jump of the -sssD A from the 5 '  end to the 3' end of the 
genome. This jump requires the degradation of the 5 '  end of the RNA genome 
that has been replaced by the fom1ation of ssDNA by the aid o f  the RNase H 
activity of RT. This step faci l itates the binding of  the ssDNA to the R sequences 
at the 3 '  end of the genome. 
3 .  The binding o f  -sssDNA provides a suitable primer-template structure which 
helps in the process of the elongation of -sssDNA to fOlm the long minus-strand 
products. 
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Figure 104. Process of reverse transcription of the retroviral genome, 
[adapted from Retroviruses, 1 997] 
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4. The primer needed for the synthesis of  the plus strand DNA is created by the 
digestion of the genomic RNA in which a smal l  portion is  resistant to degradation 
cal led the pol ypurine tract (ppt) .  The ppt serves as a primer for the synthesis of 
plus strand D A using the minus strand DNA as a template. The synthesis takes 
p lace towards the -
, 
end by copying the U3,  R and US sequences and then 
elongated to copy a portion of the tRNA. The result ing sequence is cal led plus 
strand strong stop DNA (+sssDNA) .  
5 .  This is fol lowed by the removal of tRNA by the a id  of  the RNase H acti i ty  of the 
reyerse transcriptase. 
6. After the removal of the tRNA the 3 'end of the +sssDNA pairs with the 3'end of 
the -sssD A formi ng a c ircular intem1ediate that shares the pbs sequences. 
7 .  Both strands are now elongated. The extension of the -sssDNA is coupled with 
the displacement of the +sssD A from the 5' end. As the elongation of the -
sssD A occurs, the +sssDNA is transfened to the 3' end. At this point, this 
c ircular shape i s  opened and results into a l inear D A. 
The result  of  reverse transcription is the creation of a double stranded DNA molecule 
with long terminal repeats ( LTRs) at ei ther ends. The U3 at the 5'  end comes from the 3' 
end, whi le the RlU5 sequences at the 3' end come from the 5 '  end of the virus genome. 
C. I n tegrat ion  
Integration is the process in which the viral DNA integrates with the host chromosomal 
D A .  Integration is a crucial feature in the l i fe cyc le  of  the retroviruses and is required 
for efficient replication of retroviruses. Mutant retroviruses that are unable to integrate 
1 3  
cannot spread the infection. A key step that must occur before integration is the entry of 
the \ ira! D into the nucleus. Thi s takes place due to the presence of nuc!ear 
localization signals on the viral D A. The actual integration takes place by the aid of the 
integrase protein ( IN), which acts to insert the l inear DNA formed previously during 
reverse transcription into the host chromosome (reviewed in Goff, 200 1 and Brown, 
1 997). 
The integration process takes place in two steps ( Fig. I . 5 ) : 
1. The first step includes the removal of the two terminal nucleotides at the 3 '  end of 
the l inear DNA by the IN protein that results in the formation of  recessed 3'  ends 
and protruding 5' ends. 
2. During the second step, the 3 'OH ends are used in a strand transfer to attack the 
phospho diester bonds of the cel lular DNA, making a breaks in the cel lul ar DNA 
that a l lows the v iral DNA to integrate successful ly in these breaks. 
In the retroviral l i fe cyc le, the integrated proviral DNA is the template used for 
transcription of  the viral mRNAs. Therefore, formation of  an integrated proviral DNA is 
a cruc ial part in the repl ication cycle.  
D .  Transcript ion and T ra n s lation 
After the integration of  the provirus inside the host cel l ,  transcription of  this proviral 
D A starts to recreate the full-length viral RNA genome and spl iced RNA molecules that 
serve as templates for the production of viral proteins. Retroviral  transcliption takes place 
by the aid of  the host cell RNA polymerase II ( Fig. I .6). Because there are two similar 
L TRs in the proviral DNA, transcription may begin at both the 5' or the 3 '  ends al though 
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Figure I.S. Steps in the integration of the v i ral DNA .  
[adapted from FUl1damental Virology, 200 I ]  















Figure 1.6. Overview of retroviral transcription and RNA processing: A typical 
proviral structure (A) v i th identical 5' and 3' L TRs. The horizontal arrow marks 
the start s i te of transcription. The ertical arrow denotes the site of 3' end processi ng 
and poJyadenylation i n  the RNA transcript. A l l  v i ruses synthesize fu l l  length 
genomic A (8). The subgenomic-sized transcripts i l l ustrate some of the possible 
products of alternat ive spl ic ing. In  simple retroviruses (C), only a single spl ice 
donor, or, occasionally, two spl ice acceptors are used. In complex v iruses ( D), 
mUlti ple spl iced products are found. (TR) transcript ional control elements that 
functi on 111 D A; (P A) polyadenylation and 3 '-end processi ng signals that function 
in RNA; (CAP) posttranscriptional mod ification of 5' termin i  of all transcripts; (SD 
and SA) spl iced donor and acceptor signals for spl i c ing (C) ;  (AAA) 
polyadenylat ion of  3' tennini of a l l  transcripts. 
[adapted from Retroviruses, 1 997] 
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the 5 '  LTR is general ly more ut i l ized than the 3 '  LTR. The full length RNA transcript 
contains a copy or all the information encoded in the pro iral DNA in addition to a short 
direct repeat at each end cal led "R' which is important for strand swi tching during the 
reverse transcription process. In simple retroviruses, only a single spl ice donor (SD) or 
two spl ice acceptors ( SA) are used. But in compJex retroviruses multiple splice donors 
and acceptors are used (reviewed in Rabson & Graves, 1 997). 
R A splic ing is the process by which part of the RNA sequences are removed 
and the remaining sequences are l igated to give a continuous frame for translation. After 
complete transcription of the proviral D A into spl iced and unspl iced RNA, these 
retroviral  RNA are transported outside the nucleus to the cytoplasm. The mechanism by 
which these RNAs are transported is not completely clear but involves the presence of 
cis -acting sequences (such as the constitutive transport element (CTE) in M PMV or Rev 
Responsive E lement (RRE) in lentiviruses) on unspliced or part ial l y  spliced RNAs that 
interact with either viral ( such as Rev in H IV, S IV and F IV)  or cel l ular transpOli proteins 
(such as CRM- 1 )  to move these RNAs out of the nuc leus and into the cytopJasm for 
translation and incorporation into the newly forming virus partic les (reviewed in Goff, 
2001, Rabson & Graves, 1 997).  
E. Assembly and B u d d i n g  
The assembly  process is  init iated by the gag, pro, pol and env genes which are common 
to al l  retroviruses. The gag gene is translated into a polyprotein which has a major role in 
the assembly process. I t  contains the sequence needed for MA, CA and NC proteins and 
is  translated from the unspl iced viral RNA on free ribosomes in the cytoplasm. The 
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products of the pro and pol genes provides the enzymes- the protease CPR), reverse 
transcriptase (RT), and integrase ( IN)- critical [or virus replication and are synthesized 
from the same unspl iced RNA as the gag. Spl iced RNA transcripts are used to make env 
proteins yia the golgi apparatus that are ultimately delivered to the membrane of the host 
cel l for the assembly process. This is fol lowed by the maturation of the virus particles 
using the viral protease to c leave the large polyprotein precursors into the mature protein 
subunits such as MA, CA and C proteins that fonn the mature infectious virus particle .  
In some retroviruses, vilion maturation takes place before budding (such as types B & D), 
whi le in others (such as H IV), pa11icie maturat ion takes place after budding ( reviewed in 
wanstrom & Wi l ls  1 997) .  
Brief History and Significance of FIV 
Feline immunodeficiency virus ( FlY) was isolated from a l arge multiple cat  household in 
Petaluma, California in 1 986 (Pedersen et  a I . ,  1 987).  This discovery was initiated by an 
outbreak of acquired immunodeficiency-l ike disease among a l arge group of fel ine­
leukemia-virus-negative cats housed in the same pen ( Pedersen et aI . ,  1 987) .  S ince that 
t ime, FIV has been the target of intensive vaccine development efforts, and nowadays, i t  
is  becoming the lentivirus of  choice to be used as safe vector in gene therapy. 
Epidemiology 
A. H ost Ra n ge:  All  of the present isolates of FIV have come from domestic cats. 
However, many sera from wild Felidae, which includes African l ions and cheetahs, Asian 
l ions and tigers, South American j aguars, and North American bobcats and panthers have 
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shown cross-reactivity with structural antigens of FrY (Barr et a l . ,  1 989; Letcher et a I . ,  
1 99 1 :  Lutz et  aI . ,  1 992; Olmsted et  aI . ,  1 992). 
B. Geogra p h i c  Distri b u tion: FlY has been ident ified in many regions of the United 
tates, Canada, E urope, South Africa, Japan, China, Austral ia, and New Zealand. 
Dome tic cats spread from E urope to these countries with the early traders and explorers 
thousand of years ago which suggests that FrY has infected cats for a long time (reviewed 
in Pedersen, 1 993) .  
General Characteristics and Morphology 
FrY has a \\'orld\vide distribution among feral and domesticated cats and in many cases 
induces immunodeficiency disease analogous to that of human AIDS .  FrY is genetically 
homologous to HrY in genome organization and l ike H rY, exhibits enormous sequence 
variation throughout the range of host spec ies (reviewed in Pedersen, 1 993) .  
The virus buds from the plasma membrane in the same way as other retroviruses. 
The virions are around 1 05- 1 25 nm in diameter, the shape is  spherical to el l ipsoid, and 
ha e Sh011, poorly defmed envelope projections. The virus buds in a typical crescent­
shaped appearance of C- and D-type retro iruses. 
FrY has a buoyant density in sucrose of 1 . 1 5- 1 . 1 7  glcm3 . I t  is  damaged by 
common viruc idal concentrations of several disinfectants l ike chlorine quaternary 
ammonium compounds, phenol ic compounds, or alcohol and becomes inactivated by 
heating at 60DC for few minutes. I t  can survive for over 2 years in tissue culture media at 
-70DC (reviewed in Pedersen, 1 993 ) .  
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Cell Tropism of F l V  
nl ike primate lenti\ ' iruses FI does not use the CD4 receptor for the virus entry but the 
chemokine receptors ( Brown et a l . ,  1 99 1 ' Wil lett et a l . ,  1 997). FIV repl icates in primary 
fel ine blood mononuc lear cel ls thymus cel l s, and spleen cel ls that have been stimulated 
with concanavalin A (ConA) and maintained on human recombinant interleukin-2 ( lL-2) 
( Pedersen et a1 . ,  1 987 ;  Yamamoto, et a l . ,  1 988) .  The cellular tropism of FIV is  restricted 
to feline cel ls. FlV wi l l  not replicate in non-fel ine cell l ines such as primary ConA- and 
IL-2-stimulated canine blood mononuc lear cel l s  and lymphocytes from other species 
(Yamamoto et a1 . ,  1 988) .  There is some evidence that F lV wi l l  infect some human cell 
I ines ill vitro, but virus repl ication is restricted. The restriction of the virus tropism seems 
to be at the virus entry level into the host cel l  and at the level of gene expression 
(Miyazawa et a1., 1 992). The sequence variabi l ity found in the FlV envelope genes is 
direct ly related to its host range ( Hohdatsu et a1 . ,  1 996' Pancino et a1., 1 995 ; Greene et 
a1 .  1 993 ' Maki et aL, 1 992; Phi l l ips et a1., 1 990) whi le  the activity of F IV LTR varies 
with different strains of FlV and in different host cel l  lines (Sparger et a1 . ,  1 992; 
Miyazawa et a1 . ,  1 992 and 1 994) . 
Gene Therapy 
Genes are considered the basic functional units of heredity which are calTied on 
chromosomes. Genes are very speci fic sequences of nucleotides that have codes for the 
formation of proteins that perform most l i fe functions and make the majority of cel lular 
structures. When genes are changed, the encoded proteins are unable to do their normal 
functions, so genetic disorders can occur. That is why gene therapy is used for treating 
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defective genes "" hich are responsible for disease development (http ://www.oml.go / 
sci/techresources Human_ Genome/medicine/genetherapy.shtml ) .  
Researchers are using di fferent techniques for treating defective genes. Of these, a 
nomlal gene can be inserted into a non-specific place within the genome to replace a 
defective gene. Towards this end, a gene carrier cal led a "vector" is used to del iver the 
desired gene to the patient 's  target cel ls .  Nowadays, the most common vector is a virus 
that has been manipulated to carry normal human DNA. Scientists have tried to take 
advantage of this and minimize the virus genome to remove disease-causing genes and 
insert therapeutic genes ( http://www.oml.gov/sciltechresources/Human _ Genome/ 
medicine/genetherapy. shtrnl) .  
A. Non-v i ral opti o n s  for gene th e rapy 
There are several non-viral options for gene del ivery. The simplest method is  the direct 
introduction of therapeutic D A into target cel ls .  The l imitation is that it can be used 
only with certain tissues, is inefficient, and requires a very l arge amount of DNA. 
Another non-viral approach includes the creation of an arti ficial  l ipid sphere . This 
l iposome, which has the therapeutic DNA, is capable of passing the DNA through the 
target cel l 's membrane. Researchers are also experimenting with introducing a 47th 
(art ific ial human) chromosome into target cel ls. This chromosome would exist 
independently alongside the standard 46 chromosomes--not affecting their workings or 
causing any mutations. I t  would be a large vector capable  of carrying substantial amounts 
of genetic code, and scientists are hoping that because of its construction and autonomy, 
the body's immune systems would not attack it. The l imi tation is the difficul ty in 
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deli ering such a large molecule to the nucleus of  a target cel l  
(http :.lwww.oml .gov/sci/techresources/ Human _ Genome/medicine/genetherapy.shtml) .  
B. Vi ra l  Vector fo r Gene Therapy 
There are several types of  iruses that have been used as gene transfer vectors, including 
adenoviruses, adeno-associated iruses, herpes simplex vi rus and retroviruses. E ach has 
i ts own advantages and disad antages that have been discussed below: 
Adel10viral vector : A class of viruses with double-stranded DNA genomes that cause 
respiratory, intest inal, and eye infections in humans. TIle viruses infect with high 
efficiency but don't  integrate their DNA in the host cel l .  Adenoviruses are able to 
transfer genes into most tissues of the body (reviewed in Culver 1 996). These vectors 
have many ad antages; 1 )  h igh efficiency of gene transfer regardless of  the state of  the 
t issue. In other words, they can insert the genes in both dividing and non-dividing cel ls .  
2) They can produce virus at very high ti ters and 3) these viruses can be effectively 
del ivered using aerosol .  As in all vector systems, the adenoviral  vectors also have many 
disadvantages including 1 )  Lack of  t issue speci fic i ty. These vectors appear to be able to 
infect a l l  cel ls ,  which could results in toxicity in normal sl.llTounding cel l s .  2) Lack of 
abi l ity to integrate into the host cel l ,  thus, long term expression of  these vectors is  a 
problem. 3 )  III vivo application of adenovirus vectors results in an immune response to 
the viral  inocul um that can l imit the survival of the transduced cel ls. 
Adello-associated viral (AA JIJ vectors: AA V are a c lass of  smal l ,  single-stranded DNA 
viruses that can insert their genetic material at a spec ific site on chromosome 1 9  
(reviewed in Culver, 1 996) .  AA V is considered a dependent virus because i t  requires co-
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infection with another virus to be infectious. The advantages of AA V is i ts abi l i ty to 
transduce a variety of cel l types at high efficiency' also it is not associated with any 
known human diseases, and it is not immunological ly reactive. The l imitation of this 
vector system is that the recombinant vectors may lose their non-random integration 
which may increase the possibi l ity of insertional mutagenesis .  Also, these vectors can 
carry only very smal l  gene sequences, excluding the possibi l i ty of gene therapy with 
l arge genes. 
Herpes simpk-c viral (HS V) vectors: HSV is a c lass of double-stranded DNA vimses that 
spec ifical ly inJect neurons. 1l1ey are lyt ic  non-integrating DNA vimses and have the 
abi l i ty to generate h igh viral ti ters and carry large genes, but their l im itation is that they 
can reactivate latent herpes virus (reviewed in Culver, 1 996). 
Retroviral vectors: Retroviral vectors have advantages when compared to many other 
gene transfer systems (reviewed in Mi l ler, 1 997) .  They have the abi l i ty to infect a wide 
range of cell types. They integrate genetic material into the target cel ls, so that the host 
cel ls as wel l as a l l  the subsequent progeny of the host cel l  maintains the therapeutic gene 
stably for the l i fe of the cel l .  Unl ike the other vira l  system, retroviral vectors can carry 
l arge coding capaci ties and important ly, the host does not el icit  an in1mune response to 
the retro i ra l  vectors. They can also express the gene of interest at high levels. One of the 
i mportant advances in retroviral  vector design has been the development of a retroviral 
packaging cell l ine which provides al l the vira l  stmctural proteins in trans from 
independent vectors thereby prevent ing the fom1ation of a repl ication competent virus 
( Mann et a 1 .  1 98 3 '  Watanabe and Temin 1 983) .  
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Retroviral ectors based on "lentiviruses" such as H IV and simian 
immunodefic iency virus ( IV) have the added advantage that they can also infect non­
dividing cel ls (Mi l ler, 1 997).  This is a major requirement for gene therapy in most cases 
s ince cel ls of the target organs of gene therapy, such as heart, l iver, lung, muscles brain, 
etc. divide very slo\vly. However the use of primate lentiviral vectors in humans are not 
very promising because it raises some important safety concerns such as the generation of 
repl ication-competent i rus with related endogenous viruses. Therefore, FIV is being 
explored as one of the possible alternatives for gene therapy. Phylogenetic comparison 
with other primate lentiviruses has shown that FIV is only distantly related to H IV or SIV 
( Bachmann, et  a1. 1 997;  E lder, e t  a1 .  1 993 ; Olmsted, et a1. 1 989; Olmsted et aI . ,  1 992; 
Talbott et a1. 1 989). The use of FIV based lentiviral vectors is promising for many other 
reasons: 1 )  primates are not the natural host of FIV, 2) FIV can infect and propagate in  
dividing as  wel l  as  non-dividing cel ls ( Johnston et  aI. , 1 999; Poeschla et aI. , 1 998a; Wang 
et aI ., 1 999), and 3) fel ine models  are much cheaper and eas i ly avai lable (Mi l ler, et al. 
2000) .  
RNA E ncapsidation 
RNA encapsidation is the process by which retroviruses package their full- length, 
unspl iced genomic RNA preferential ly over spliced viral and cellular RNAs into the virus 
part ic les (reviewed in Berkowitz et aI. , 1 996 and Swanstrom and Wi l ls, 1 997). The 
speci flci  ty of packaging has been attributed to the interaction between a cis-acting 
sequence, the packaging signal (E or '¥) on the retroviral RNAs, and the trans-acting 
nucleocapsid region of the Gag polyprotein.  The nucleocapsid region of the Gag 
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polyprotein provides zinc-binding domains that are critical elements for the interaction 
with the packaging signal present in the retroviral genomic RNA (Dorfrnan et a I . ,  1 993 ; 
Gorelick et a I . ,  1 993 ; Sakaguchi et a I . ,  1 993;  Zhang and Barklis ,  1 995). The packaging 
signals, in turn, are thought to interact with the nucleocapsid protein at a structural level , 
and as such have been shown to fold into complex stem loop structures ( Berkowitz et a1 . ,  
1 996). This may partial ly  explain cross-packaging between retroviruses that l ack any 
apparent sequence simi l arity between each other, such as murine leukemia and spleen 
necrosis viruses MLV/SNV ( Certo et a I . ,  1 998) or H IV/FN (Browning et a I . ,  2001 ). 
The primary RNA packaging determinants (the major packaging signal )  l ie at the 
5 '  end of the retroviral  genome; however, the exact sequence requirement di ffers between 
different retroviruses. For some retroviruses, such as SNV, Rous sarcoma virus (RSV), 
and fel ine leukemia virus ( FeL V),  the major packaging signal l ies within the 5' UTR 
between the pbs and the start of gag (reviewed in Linial and Mil ler 1 990) ; whi le  in 
others, the packaging signal seems to extend into the 5 '  end of  the gag gene, such as for 
MLV (Bender et a1 . ,  1 987) ,  bovine leukemia viruses ( B L  V) (Mansky et aI., 1 995), 
MPMV ( Schmidt et a1. , 2003), and H N- l  ( Parol in et a1. ,  1 994). However, other regions 
of the viral genome have also been impl icated as containing minor packaging 
determinants, such as the 3 '  UTR (Sorge et a1 . ,  1 983 ;  Ashcoff et a1 .  1 999' Yu et aI. , 
2000) and the LTR (Murphy and Goff, 1 989; Clever et aI . ,  1 999; Helga-Maria et a1 . ,  
1 999; Guan e t  a1. , 200 1 a). In general ,  the s imple  retroviruses are thought to  contain more 
discrete packaging determinants local ized to smal l  segments of the 5 '  end of the viral 
genome, whi le  those of the complex retroviruses are thought to be more spread out 
( Berkowitz et a1. , 1 996; Banks et a1 . ,  1 997) .  The only exception to the rule are the 
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spumaviruses. There is some data that suggests that a central region in pol may be 
involved in R packaging ( Heinkelein et a I . ,  1 998; Erlwein et a I . ,  1 998) .  
With an increase in studies on retroviral packaging detemunants, the emerging 
picture suggests that the location of the primary packaging determinant in relation to the 
major splice donor (mSD) may be more instructive as to how different retroviruses have 
developed strategies to differentiate between full  length and spl iced RNAs. For example, 
the core packaging signals oUhe y retroviruses SNV, MLV and FeLV are l ocated 
downstream of the mSD in the viral intron, thus al lowing for packaging only of the 
unspl iced viral RNA containing the If' over spl iced mRNAs which lacks it  ( Watanabe and 
Tenun, 1 982; Adam and Mi l ler, 1 988 ;  B ums et a I . ,  1 996) .  Furthermore, in ML V, the 
genomic RNAs are sorted into two pool s--{)ne destined for translation, while the other 
reserved for packaging ( DoID1an and Lever, 2000) .  However in the ex retroviruses such 
as ALSV, the packaging signal is located upstream of the major SD, al lowing for both 
spl iced and unspl iced mRNAs to be packaged into the viral  genome ( B anks et a l . ,  1 998). 
Since ellv rnRNA in these viruses is  the only spl iced species produced sequestrat ion of 
this mRNA spatial ly  in the rough endoplasmic ret iculum may keep it away from the Gag 
polyprotein which is expressed from the free ribosomes in the cytoplasm, thus al lowing 
specific packaging of the full- length RNA wluch is expressed in the cytoplasm ( Banks et 
a l .  1 999) .  
S imilarly, the core packaging determinant in the f3 retrovirus, MPMV, l i es 
upstream of the mSD (Guesdon et a I . ,  2001 ; Schmidt et a l . ,  2003 ); however, sequences 
within the 5 '  end of gag seem to be equal ly important for packaging (Schrnidt et a1 . ,  
2003) .  Since regions within gag are part of  the intron in M P MV, the presence of  
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packaging detemunants within the 5 '  UTR upstream of the SD but extending into gag 
may help MPM differentiate between spl iced and unspl iced mRNAs. Using 
biochemical and phylogenetic analyses, and computer modeling, the first 275 bp of the 
MPM 5 '  UTR and gag have been predicted to fold into a complex secondary RNA 
structure containing eight stem loops ( Harrison et a I . ,  1 995)  ( Fig. 1 . 7,  panel A). 
Mutations within the fIrst four stem loops present with in the 5 '  UTR have revealed that 
only the sequences within the first stem loop and not the loop structure itsel f are critical 
for MPMV RNA encapsidation (Mustafa et a I . ,  2004) whi le  the role  of structures within 
gag towards packaging sti l l  needs to be determined. 
A some\\ hat different picture is observed with the 8 retroviruses, the BL V/HTL V 
group of viruses that are sinular to the spurnaviruses in that the major spl ice donor resides 
within the R region of the LTR. However, the s imi larity ends here. Using deletion 
analysis of  the BL V 5' region these studies have mapped the packaging signal of BL V to 
two discrete discontinuous regions downstream of the mSD that fold into stem loop 
structures ( Mansky et a I . ,  1 995 ·  Mansky and Wisniewski , 1 998). The first region 
comprises of the entire 5' UTR downstream of the pbs and ends within 70 bp of the gag 
region in the matrix domain, whi le  the second region exists more downstream of the gag 
gene in  the capsid domain. Region 1 folds into two stem loops that exist within the gag 
sequences only, while Region 2 folds into a s ingle stem loop structure. Al l  three stem 
loop structures seem important for packaging, and interestingly, replacement of the 
sequences containing the two regions with homologous regions from either HTLV- l or 
HTLV -2 results in substantial packaging, suggesting that the packaging signals of  the 
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Figure 1 .7_  The predicted secondary RN A structure of the 5' end of A) 
MPMV [adapted from Harrison et a I . ,  1 995] ,  B) HlY [adapted from Clever 
et a l . _  2002], and C) S lY [adapted from Strappe et aI . ,  2003] genomic RNAs_ 
The major cis-acting sequences of the v i rus are h ighl ighted by the gray 
shading such as the primer binding site (PBS), d imer int it iation site (DIS), 
the gag i n it iation codon (AUG), spl ice donor (SD), polyadenylation (pA), 
and transactivating region (TAR)_ 
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incorporation of both a non- iral heterologous RNA and a chi meric murine leukemia 
virus retroviral vector R A to get cross-packaged into BL V part ic les (Jewel and Mansky, 
200 ) .  
Among the lentiviral group of retrovi ruses, the packaging determinants of H IV- l 
are the most e, tensi ely studied, presenting a complex picture upon which, most 
investigators agree. The H IV - 1  If' contains sequences both upstream and downstream of 
the major SD and extends into the gag ( reviewed in Berkowitz et a I . ,  1 996 and Lever, 
2000). I t  is multipart i te and known to have higher order RNA structures extending from 
the transcriptional start site with the TAR loop to the 5 '  end of gag ( Fig. 1 .  7, panel B )  
( Harrison e t  a I . ,  1 992 and 1 998;  Sakaguchi et aI . ,  1 993 ; Das e t  aI . ,  1 997; McBride and 
Panganiban, 1 996 and 1 997;  Clever et a l . ,  1 999). Three complex stem loops are present 
within the 5 '  LTR (the TAR, the poly A, and the complex U5IPB S  stem loops), wln le  the 
sequences downstream of the pbs fold into a c luster of four stem loops cal led SL I -4 
thought to contain the major packaging detemnnants of H IV .  Of these four stem loops, 
SL I and 3 are considered the most important. SL I is located upstream to the major SD, 
SL3 is located downstream of the major SD and the start of gag, and SL4, is located j ust 
downstream of the gag start codon.  S L l  is known to be responsible for RNA dimer 
fomlation, whi l e  S L3 has been shown to interact with the nucleocapsid protein. SL3 
appears to be the main stem loop which is consistently related to packaging ( Lever, 
2000), while sequences contained within SL 1 ,  may be S L4, and other sequences present 
in the viral genome may play a role  in maintaining the larger secondary RNA structure 
that forms the complex H IV - 1  packaging signal (McBride and Panganiban, 1 997 ' Lever, 
2000). However, SL 1 -4 are not sufficient in themselves in vivo for packaging and other 
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sequences upstream to L 1  are also required ( Helga-Maria, et a I . ,  1 999; Kaye, et a l .  
1 995;  McBride, et  a I . ,  1 997; Parol in ,  et  a I . ,  1 994). For example, mutation in the stem of 
the TAR element affect packaging signi ficant ly ( Helga-Mari a  et  a l . ,  1 999; Clever et  a l . ,  
1 999) whi le  sequences within the US-PBS between the poly A stem loop and S L 1  
contribute to H IV- l RNA packaging (McBride et a l . ,  1 997, Clever et a l .  1 999). 
dditionally, the GU-lich sequences found in the lower stem of poly  A stem loop and the 
U5-PB comple ' show contribution to both dimerization and packaging ( Russel l  et a1 . ,  
2002) .  Since the major packaging detemlinant of H IV -1 resides within S L3 ( found 
downstream of the m D), i ts presence on full- length genomic RNA ensures specific 
incorporation into the virions over and above the spl iced mRNAs. 
The packaging signal of H IV -2 is  less wel l -studied and controversial ,  probably 
due to the presence of a functional intron in the H IV-2 LTR (reviewed in Lever, 2000 and 
Griffm et aI. , 200 1 ) .  Although both H IV - 1  and 2 cause AIDS and maintain simi l ar 
genomic organizat ion, the two vimses have l imited sequence homology, reflecting their 
distinct evo lutionary origins ( Franchini  et a l . ,  1 987). L ike H IV - 1 ,  the sequences involved 
in H IV -2 packaging are spread out and function in a context -dependent manner. 
Although sequences both upstream and downstream of the major SD have been 
implicated in the packaging of the H IV-2 genomic RNA (Garzino Demo et a1 . ,  1 995;  
McCann and Lever, 1 997 ; Kaye and Lever, 1 999· Poeschla et a1. , 1 998b), the H IV-2 
packaging signa1s belong to the ALSV IMPMV category where the core packaging 
determinants are located upstream of the major SD ( Kaye and Lever, 1 998 and 1 999; 
McCann and Lever, 1 997 ) .  This conclusion is strengthened by the observation that H IV-
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1 proteins can cross-package not only full  length H IV-2 mRNAs non-reciprocal ly, but 
also spl iced H IV-2 mRNAs ( Kaye and Lever, 1 998) .  
Since al l  H IV-2 mRNAs maintain the core packaging determinant, i t  has evolved 
a un ique strategy to preferential ly incorporate only genomic and not spl iced mRNAs into 
the nascent virus particles. The strategy requires that the genomic RNA act as the 
template for the translation of the Gag polyprotein that would capture the co-h"anslated 
RNA in "cis " for incorporation into the virus particle ( Kaye and Lever 1 999). amed 
" cis-acting encapsidation", this strategy may also partia l ly explain why H IV -2 is unable 
to encapsidate ei ther H IV- l or H IV-2 vector RNAs in trans. 
Final ly, the packaging detemrinants of S IV RNA have started to emerge, but the 
findings are controversia l .  SIV is  more c losely related to H IV -2 than HIV - 1 ,  especial ly 
in the non-coding regions of their genome ( Patel et a1 . ,  2003) .  Like H IV -2, SIV also 
contains a functional intron within its LTR (Vigl ianti et a1., 1990; Unger et aL, 1 99 1 ) . 
The role of sequences within the 5 '  UTR towards packaging are sti l l  not c lear with Patel 
et a 1 . ,  (2003) suggesting that sign ificant packaging detenrunants are present both 
upstream and downstream of the major SD, while others showing that, simi lar to H IV-2, 
the core packaging signal of  S IV resides upstream of the major SD, perhaps in the U5 
stem and the din1erization initiation sequences (DIS) ( Fig. I . 7, panel C) ( Strappe et a1 . ,  
2003 · Guan e t  aI . ,  2000 and 200 l b; Rizvi and P anganiban, 1 993) .  The location of the 
packaging signal relative to the 5 '  methyl cap is  �470 nts (very simi lar in S IV and H IV-2, 
but much shorter in H IV - 1 )  Strappe et a 1 . ,  further hypothesize that this distance may be 
important for packaging, since it  may affect the competition between translation and 
encapsidation that the genomic RNAs must undergo. The important concl usion from 
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their observation is that for retroviruses, it is not the position of the SD relative to the 
core packaging detemLinant that dictates the strategy that the virus may use for 
encap idation, rather the distance between the cap site and the core packaging 
detem1inants. These observations are being further investigated experimental ly. 
ince incorporation of the genonLic RNA into the budding i rion i s  one of the last 
step in the retroviral l i fe cyc le, successful packaging of the genomic RNA is dependent 
upon a host of steps that should have taken place successful ly  ( Fig. 1 . 8) .  These steps 
inc lude binding of the virus to the cell  sLUface fusion of the two membranes and entry of 
the viral core into the cytoplasm. This is fol lowed by successful reverse transcription of 
the incoming genomic RNA into cD A, transport of  the cDNA to the nucleus, i ts 
i ntegration into the host genome, i ts subsequent transcription into mRNAs, and fmal ly 
successfu l  transport of the ful l-length genomic RNA from the nucleus to the cytoplasm 
into the correct cel lu lar compartment where assembly takes place. The emerging 
paradigm of studying RNA packaging dictates that when understanding the effect of the 
i ntroduced mutations, one must keep in mind that an al teration of any one of the steps 
outl ined above could negatively affect RNA packaging, without affecting the packaging 
process directly (Lever, 2000) .  
Among lentiviruses, our interest has  been to  define the packaging signal of FIV, a 
lentivirus of non-primate origin. ot much work has been done to understand how 
lentiviruses of non-primate species package their RNA genomes. We are also interested 
i n  FrV RNA packaging since FIV -based gene transfer vectors are being considered as a 
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potential ly practical ector system for human gene therapy ( aldini et a I . ,  1 996; Johnston 
et a I . ,  1 999: Poeschla et a I . ,  1 998a:  Wang et a1 . 1 999· Browning et a I . ,  200 1 ) .  This is 
becau e of the greater evolut ionary distance bet', een the primate and fel ine lentiviruses 
which rna reduce the possibi l ity of generation of recombinants between the two viruses 
which may encounter each other in the patients being treated. Earl ier, we have 
demonstrated that F lY RNA can be cross-packaged, reverse transcribed, and integrated 
by the primate lentiviruses such as H IV - 1  and SIV in a reciprocal manner ( Browning et 
a I . ,  200 1 ) .  This observation leads to the urgency of mapping the sequences responsible 
for FlY RNA packaging in order to e l iminate such sequences from the integrated transfer 
vector, resulting in the establ ishment of safer and more effective F lY gene transfer 
vectors. 
The packaging signal of FIV seems to reside within the 5 '  UTR and the first 350 
bp of gag since these sequences are sufficient to a llow efficient transduction of marker 
genes carried by F lY-based vectors (Browning et a l . ,  2001 , Joh11ston et a l . ,  1 999; 
Poeschla et a l . ,  1 998a). These studies were fol lowed by a more systematic deletion 
analysis of  the FIV 5' UTR and gag sequences in our laboratory using subgenornic 
constructs and slot blot analyses on virion and cel lular RNAs. l 1ese studies revealed that 
l ike H IV - 1 ,  the F lY packaging determinants were complex and multipartite consisting of 
t',,,'o discontinuous core regions, one located in the 5' UTR upstream of the major SD 
from RfU5 to  the first 1 20 bp of UTR, while the other found in  the first 1 00 bp of the gag 
gene ( Browning et a l . ,  2003 a & b) .  These two core elements were equal ly important and 
simultaneously required for packaging since deletion of one of these elements reduced 
packaging to a simi lar 4-6 fold level , whi l e  deletion of both elements together reduced 
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packaging to a drastic 40- fold 10\ er level, but not completely ( Browning et a 1 . ,  2003 a & 
b .  
Another group studying FlY RNA packaging confinned some of these 
observations, whi le rai sing many questions as \ el l  ( KemJer et a1 . ,  2002 & 2004). Using 
R ase protection assays on virion and cel lular RNAs of ful l  length genomic and 
sub genomic constructs, these studies showed that indeed the first 90 bp of gag were 
critical for FIV RNA packaging whi le the region downstream of the mSD and beginning 
of gag \ as dispensable in agreement with our observations. However, they suggested 
that the major Fry packaging determinants were constrained to the RlU5 region with the 
first 1 -+ bp of the 5 ' UTR also playing some role. Additional ly, they found no role of 875 
bp of env or the 3 '  L TR in FlY RNA packaging. 
Objectives 
This proj ect was undertaken to get a c learer picture of the packaging determinants of 
F IV .  We started with observations that FlY packaging determinants seemed to reside 
within two discrete regions (Browning et a 1 . ,  2003 a & b) and asked whether the 
sequences in between the two core packaging detelminants were i mportant for packaging. 
S ince other studies came out during the course of our investigations ( Kemler et a 1 .  2002 
& 2004), we further asked what the role  of the F lY L TR sequences was towards 
packaging and which sequences constituted the core packaging determinants. 
To answer these quest ions, two independent approaches were taken to [me map 
FIV RNA packaging determinants using both genetic and structural approaches: 
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1 )  An incremental deletion analysis \J as conducted of the region in between the two core 
regions in subgenomic constructs. In a separate series, the deleted region was 
substituted simultaneously with heterologous sequences of the same length to 
detennine whether the spacing between the 1:\'10 core regions was important or the 
actual sequences themselves (Chapter I I I ) .  
2)  The RJU 5 region at  the 5'  end and the 3'  L TR at the end of the FIV genome were 
independent ly tested in sUbgenomic and heterologous vectors for their effects on FlV 
RNA packaging (Chapter IV) .  
These vectors were tested in an in vim packaging assay using semi-quantitative RT-PCR 
analysis of  virion and cytoplasmic RNAs. Test of  these constructs revealed that, as 
suspected earli er, FlV packaging determinants are complex and multipartite. More 
specifical ly, we found that: 
1 )  The first - 1 50 bp of the 5 '  UTR and - first 1 00 bp of gag constitute the core 
packaging determinants (Chapters I I I  & IV).  
2) The region in between the two core packaging determinants is  neither required for 
vector RNA packaging nor propagation of the F l V  transfer vector RNA (Chapter I I I ) .  
3 )  F I V  RJU5 contains minor packaging determinants that increase the packaging o f  FIV 
transfer vector RNAs by 2-3 fold (Chapter IV) .  
4)  Contrary to publ ished findings, the FIV 3 '  LTR and in particular the U3 region 
harbors packaging determinants of minor nature (Chapter IV) .  
Final ly, using computer predictions of sequences found to  be important for FlV 
RNA packaging in om functional assays, we ident ified a specific structural element 
within the 5 '  end of the FlV genome that may have a cri t ical role  in FIV RNA packaging. 
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Chapter II 
MATERIALS & METHODS 
Genome N u mbering System 
ucleotid designation for FI Petaluma (34TF I 0) strain is based on GenBank accession 
number M253 1 (Talbott, et aI, 1 989). 
Plasmid Construction 
Frv packagi n g  constru ct. The packaging construct, MB22 which provides the viral 
structural proteins, has been described previously (Browning et aI . ,  200 1 ) ( Fig. I L l ) .  In  
brief it  uses the human cytomegalovirus (hCMV) as promoter to express a l l  the genes of 
FIV except ell)! and orj2, and uses the bovine growth hormone ( BGH)  poly A sequences 
to stop transcription . 
E n velope express ion  const ruct.  The vesicular stomatit is virus (VSV) envelope protein 
G expression construct (VSV-G), MD.G, was provided by Dr. Didier Trono (Salk 
Insti tute, La Jol l a, CA) and has been described previously (Naldini ,  e t  ai, 1 996). 
F I V  control t ra nsfe r  vector. The control vector, MB 1 5 , has been described previously 
(Browning et a I . ,  200 1 ) ( Fig. I L l ) . In brief, i t  contains the entire 270 bp of 5' untranslated 
region ( UTR) 1 00 bp of gag and al l  the necessary cis-acting sequences needed for 
packaging, reverse transcription and integration.  
T ra n sfer vectors with delet ions between the two core regions. AG002 through AG004 
are transfer vectors containing deletions in the 5 '  UTR. Of the 270 bp 5 '  UTR, we 
maintained 90, 1 20 and 1 50 bp from the 5 '  end of the 5 '  UTR while deleting the 1 80, 
1 50, 1 20 bp upstream of the gag gene, respectively. These vectors were generated 
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Figure 1 1 . 1 .  Schematic representation of F l Y  packaging constnlct M B22 and F N  control transfer vector MB 1 5 . 
CMY, human cytomegalo\'inls promoter-enhancer; SY, simian i nls 40 early promoter; hyg, hygromycin B 
phospho/rans/erase gene; CTE, constitutive transport element of M PMY; 'jJ packaging signal .  
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through splice o\erJap extension (SOE) PCR (Gibbs et a 1 .  1 994) using TR394 as a 
template. To generate these vectors, two individual PCRs were performed using hybrid 
primers which resul ted in two overlapping PCR products ( Fig. 1 1 .2). These two primary 
products were annealed at complementary regions and ampl ified using outer primers. 
Deletions in the 5 '  UTR were generated using OTR405 as the sense primer (S ;  5 '  CGCG 
TTGACA TTG A TT A T 3 ' ;  nt 229-246 of pRcCMV vector, Invi trogen, Carlsbad CA, 
representing the beginn ing of CMY promoter region) and hybrid primers with gag tai ls  
l i sted as fol lows (gag tai ls shown in lowercase fol lowed by FIV 5 '  UTR sequences 
shown in uppercase): 
90 bp delet ion : OTR568 (AS; 5 '  ccccatTAGGTCAGCAGGAGT 3 ' ;  6 bp tai l  from gag 
ATG'nt 432-446 of flY 5' UTR). 
1 20 bp delet ion :  OTR569 (AS ' 5 '  ccccatGTTAGCAGCGTCTGC 3 ' ;  6 bp ta i l  from 
gag ATG/nt 462-476 of F N  5' UTR). 
1 50 bp delet i o n :  OTR570 (AS ; 5 '  ccccatCTCGAGTCCGCTTCA 3 ' ;  6 bp tai l  from 
Gag ATG/nt 492-505 of FlY 5' UTR). 
The 1 00 bp of gag were generated using TR394 as a template and OTR503 as the 
antisense primer (AS ' 5' aaaaagcggccgcTCCCTTCTCCAAATTTTTTACTCTTCC 3 ' ;  
F N  gag n t  727-70 1 ,  sequences i n  lowercase represent artificial  s ites created for cloning 
purposes while FN sequences are shown in  upper case) and hybrid sense primers 
containing 5 '  UTR tai l s  corresponding to the deletions l isted as fol lows ( 5 '  UTR tai ls 
shown in  lowercase fol lowed by gag sequences shown in uppercase) : 
90 bp delet i o n :  OTR57 1  (S ;  5 '  gacctaATGGGGAATGGACAG 3 ' ;  6 bp ta i l  of 5 '  UTR 
corresponding to the 90 bp deletion Int 628-642 in gag) . 
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Figure I l . 2 .  Schemat ic representat ion of transfer vectors contall1l11g deletions between the two core 
regions. The 5 '  UTR and gag fragments were ampli fied separately us ing hybrid primers. The UTR primers 
contained gag tai l s  and the gag primers contained UTR tails, resulting in products A & B. These two 
products \ ere annealed and re-ampl ified using outer primers, result ing i n  a PCR product conta in ing the 
requi red deletions. These products were digested and l igated back to create the final vectors, AG002-
AG004. CMV, human cytomegalovirus promoter-enhancer; SV, simian v i rus 40 early promoter; hyg', 
hygromycin B phosphotransjerase gene; CTE, constitutive transport element of M PM V .  
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1 20 bp delet ion : OTR572 (S ;  5 '  gctaacATGGGGAATGGACAG 3 "  6 bp tai l of 5 '  
UTR cOITesponding to the 1 20 bp deletion/nt 628-642 i n  gag) . 
1 50 bp delet i o n :  OTR573 ( ; 5 '  ctcgagA TGGGGAA TGGACAG 3 ' ;  6 bp ta i l  of 5 '  
T R  corresponding to the 1 50 b p  deletion Int 628-642 i n  gag). 
The t\ 0 primary products were combined and re-ampli fied using the outer primers 
OTR405 and OTR -03 resulting in the final products containing the deletions ( Fig. I I .2 ). 
These products \ ere digested wjth SpeI and NotI  and l igated to the simi larly digested 
large fragrnent of MTB, generating AG002-AG004 . MTB has been described previously 
(Bro\ ning, et aI, 2003a) and contains the hCMV promoter, 270 bp of 5' UTR, the SV­
Hygro cassette and FN 3 '  LTR. 
T ra n sfer vectors w i t h  s imu l ta neous deletion s/i n sertio n s  between t h e  two core 
regions. AGO 1 3  through AGO 1 5  were generated through multiple stages of cloning using 
PCR amplification ( Fig. I I . 3 ) .  The 1 00 bp of gag were amplified using TR394 as 
template, the sense primer OTR574 (S ;  5' aaaaaagcggccgcATGGGGAATGGACAG 
GGGCGA 3 ' ;  nt 628-648 in FlY gag, FN sequences are shown in upper case, whi le  
sequences in lowercase represent art ificial sites created for cloning purpose) and the 
antisense primer OTR575 (AS; 5' ccccccatcgatTCC CTTCTCCAAATTTTITACTCT 
3 ' ;  nt 727-701 in FN gag). The PCR products were digested with Not I  and Clal and 
l igated to the s imi l arly digested large fragment of MB23,  a vector similar to MTB but 
without the SV-Hygro cassette, resulting in AG006 . The fragrnents of the 5' UTR were 
amplified using TR394 as template and the sense primer OTR405 . The deletions in the 5 '  
UTR were generated using the antisense primers l isted a s  fol lows ( Fl V  sequences are 
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Figure n .3. Schematic representat ion of transfer vectors with simultaneous deletions/insertions between the 
two core regIOns (AGO 1 3-AGO 1 5 ) .  These transfer vectors mai ntained 90, 1 20 or 1 50 bp of 5' UTR with the 
addltlOn of 1 0, 1 50, 1 20 bp of heterologous sequences in the presence of 1 00 bp of gag. CMV, human 
cytomegalovi rus promoter-enhancer; SV, s imian v irus 40 earl y promoter; hygr, hygromycin B 
phospholrallsjerase gene; CTE, constitutive transport element of MPMV. 
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shown in upper case whi le sequences in 10\ ercase represent artificial sites created for 
cloning purpose): 
90 bp delet ion : OTR576 (A ; 5 '  aaaaaagcggccgcTAGGTCAGCAGGAGTTCTGCT 
3 ' . nt 426-446 in FlY 5' UTR). 
1 20 bp delet ion : OTR577 (AS; 5 '  aaaaaagcggccgcGTTAGCAGCGTCTGCTACTGC 
3 ' ;  nt 456-476 in FI  5 '  UTR). 
1 50 bp delet ion : OTR584 (AS; 5 '  aaaaaagcggccgcCTCGAGTCCGCTTCACTAGAG 
3 ' ;  nt 486-506 in FI  5 '  UTR). 
The result ing PCR products were digested with Spe I  and Not l  and l igated to the similarly 
digested large fragment of AG006, creating AG007, AG008 and AG009 fol lowed by the 
insertion of the SV -Hygro cassette into the Cla l site generating AGO ] 0 through AG0 1 2 . 
The heterologous sequences were generated by PCR ampli fication using pcDNA3 as 
template and the antisense primer OTR480 (AS ; 5' aaaaaagcggccgcgaattcCAAGTTTA 
CTCATATATACTTTAGATTGAT 3 ' ;  pcDNA3 nt 4440-44 ] 1 on Invitrogen 's  map) and 
the sense primers l isted below (sequences in lowercase represent art ificial  sites created 
for cloning purpose, while pcD A3 sequences are shown in  upper case): 
1 20 bp i n sertion : OTR583 (S ;  5 '  aaaaaagcggccgcggatccGAACGAAAACTCAC 
GTTAAGGGAT 3 ' ;  nt 432 1 -4344 of pcDNA3).  
1 50 bp i n sertion : OTR578 (S; 5 '  aaaaaagcggccgcggatccTGATCTTTTCTACG 
GGGTCTGACG 3 ' ;  nt 4290-43 1 3  of pCD A3) .  
1 80 bp i n se rt ion : OTR579 (S;  5 '  aaaaaagcggccgcggatccCAGAAAAAAAGGAT 
CTCAAGAAGA 3 ' ;  nt 420 1 -4284 of pCDNA3) .  
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The PCR products were digested "vith otI and l igated to the similarly digested large 
fragment of AGO I 0-AG0 1 2, resulting in the final clones AGO 1 3  through AG0 1 5 .  
T ra n  fer vector test i n g  the RJU5 region.  To study the effect of the RJU5 region 
independently on packaging, various constructs were made, either with or without the 
R 'U5 region, in both the heterologous and homologous contexts ( Fig. I I .4) .  
R/U5 ill tlte heterologous COlltext. AG029 is transfer vector containing the RJU5 region 
only in pcD A3 as a backbone. The RlU5 region was ampl ified using pCMV/RU5 as a 
template Mustafa, et a ! .  2005) OTR399 as the sense primer (S ;  5 '  
cccaagcttgagctcTGTGAAACTTCGAG GAGTCTC 3 ' ;  FlY 5 '  LTR n t  203-223 U3/R 
j unction), ( lowercase denotes arti ficial sites created for cloning purpose, while FlY 
sequences are shown in upper case) and OTR459 as the antisense primer (AS; 5 '  
aaaaaagcggccgcACTGCGAAGTTCTCGG CCCGG 3 ' ;  FlY n t  3 57-337, end of U5) .  The 
resulting PCR product was digested with HindIl I  and Notl ,  l igated to the simi larly 
digested large fragment of pcDNA3 fol lowed by insertion of the SV-Hygro cassette at 
the )tbaI site, generating AG029. 
R/U5 + 90, 120, or 150 bp of 5 '  UTR + 1 00 bp gag ill the heterologous context. These 
vectors were made through multiple stages of c loning by modifying pcDNA3 where the 
region between Ndel site (nt 485)  and the art ificial ly created Clal site (nt 95 1 )  was 
removed and replaced by the region between the Ndel site and the CIaI site of AG007 
through AG009 (consisting of RlU5 + 90, 1 20, or 1 50 bp of FIV 5 '  UTR + 1 00 bp gag, 
respectively). TIns was fol lowed by insertion of the SV -hygro cassette at the Xbal site (nt 
984) of pcDNA3, generating AG026, AG027 and AG028. 
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Figure I 1.4. Schematic representat ion o f  constructs testing the effect o f  R/U5 region o n  packaging. A) 
Transfer \ ectors with RlU5 region in  heterologous context. 8) Transfer vectors lacking the RlU5 region in 
the heterologous context. C) Transfer vectors with or without RfU5 region i n  the homologous context. 
CMV, human cytomegalovirus promoter-enhancer; SV, simian virus 40 early promoter; hygr, hygromycin 
B phosphotrallsJerase gene; CTE, constitutive transport element of MPMV. 
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R/U5 + 2 0 bp of 5 '  UTR + 100 bp gag ill the heterologolls COllte..y;t. This vector was 
constructed by c loning the region between the SpeI and Notl si tes of MB 1 5  (consisting of 
R 5 .  270 bp of 5 '  UTR and 1 00 bp of gag) into the SpeI (nt 250) and Notl  (nt 966) of 
pc D 3 .  This was fol lowed by insertion of the SV-Hygro cassette at the XbaI site (nt 
984) of pcD A3, generating G030. 
90, 120, or 150 bp of 5 '  UTR + 1 00 bp gag without R/U5 ill the heterologous COlltext. 
These \ ectors were generated by modifying pcD A3 where the region between Kpn I  site 
(nt 900) and the ar1i ficial ly  created Clal site (nt 95 1 )  was replaced by the region between 
the m1ificia l ly created Kpn I  site (just after the end of US)  and Clal site of AG007 through 
AG009 containing only the 90, 1 20, or 1 50 bp of 5 '  UTR and 1 00 bp of gag, 
respectively. This was fol lowed by the insertion of the SV -Hygro cassette at the XbaI  site 
(nt 984) of pcD A3, generating AG040, AG04 1 and AG042. 
2 70 bp 0f5 '  UTR + 1 00 bp gag without R/U5 ill the heterologous COllte..y;t. This vector 
\\'as constructed by deleting the region between the EcoRY site (nt 95 1 )  and Notl site (nt 
966 of pcD A3 and replacing it by the region between Sfol site (just after the end of 
US)  and NotI site of M B  1 5 , which contains only 270 bp of 5 '  UTR and 1 00 bp of gag. 
This ,vas fol lo\ ed by insertion of the SV - Hygro cassette at the Xba l  site (nt 984) of 
pcD A3 generating AG03 1 .  
R/U5 ill the homologous context. This vector was constructed by deleting the region 
between the Sfal site (nt 359 of F lY just after the end of US)  and Not! site of MTB, thus 
deleting the entire 5 '  UTR and rel igating the backbone on its own, generating AG021 
which now contains only the RlU5 region in the presence of the SY-Hygro cassette and 
the 3 '  FlY LTR. 
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2 0 bp of 5 '  UTR + 1 00 bp oag without R /U5 ill the homologous COil text. This vector 
\ as made through several steps of cloning in which the region between Sfol (nt 359, just 
a fter the end of US)  and EcoRI of M B  1 5  \ as subcloned into the EcoRV and EcoRI si tes 
of p IC 1 9H .  The same region was next l ifted by digesting the subclone with Not I  and 
partial Sad digest and l igated into the same sites of M B23 , fol lowed by insertion of the 
V-Hygro cassette at the Clal site, generating AG039. 
T ra n sfer vectors test i n g  the 3' LTR. To study the effect of 3 '  LTR on packaging, 
different constructs were made to determine whether it  has any contribution to the 
encapsidation of FIV RNA into the vi IUS partic les ( Fig. 1 1 . 5 ) .  
3 '  L TR ill the homologous cOlltext. This vector was made by deleting the region between 
the SpeI and otl sites of MTB and rel igating the backbone on its own, removing all the 
5 cis acting sequences, generating AGOO 1 .  
U3/RlU5 ill the heterologous COlltext. TIlis vector was made by PCR ampl ifying the 
U31RJU5 region using pCMVIRU5 as the template, OTR657 as the sense primer (S ;  5 '  
gcggatccTGGGATGAGTATTGGAACCCT 3 ' ;  n t  9 1 20-9 1 40 of FIV; FIV sequences are 
shown in upper case while lowercase denotes art ificial  sites created for cloning purposes) 
and OTR642 as the antisense primer (AS; 5' ccatcgatTGCGAAGTTCTCGGC 
CCGGA TIC 3 ' ;  nt 9474- 9452 FIV).  The resulting PCR product was digested with 
BamHI and Clal and c loned into the same sites of pcDNA3, generating AG05 1 .  
U31R ill the heterologous cOlltext. This vector was made by  PCR ampl ifying the U3/R 
region using pCMV/RU5 as the template, OTR657 as the sense primer and OTR658 as 
the antisense primer (AS; 5 '  ccatcgatGGTTCAATCTCA AATATTIATIG 3 ' ;  nt 9409-
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Figure I I .S. chematic representation of transfer vectors test ing the effect of 3 '  L TR on 
packaging. The numbers represent the regions of F IV strain 34TF I O  retai ned in the vectors. CMV, 
human cytomegalovirus promoter-enhancer; SV, simian v i rus 40 early promoter; hyg, 
h)'grol11)'cIn B phosphotralls/erase gene; CTE, constitutive transport element of MPMY. 
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9387 o[  F I  ; Fry sequences are shown in upper case whi le lowercase denotes arti ficial 
sites created [or cloning purpose) .  The resulting PCR product was digested with Bamffl 
and fa [ and c loned into the same sites of pcD A3 generating AG052. 
U3/ trullcated R (just before poly A) ill the heteroLogous cOlltext. This vector was made 
by PCR amplifying the U3/truncated R region using pCMV/RU5 as the template, 
OTR657 as the sense primer and OTR659 as the antisense primer (AS ; 5 '  
ccatcgatCTGTGGGA GCCTCAAGGG 3 ' ;  n t  9383-9366 of FIV, FlV sequences are 
shown in upper case whi le  lowercase denotes arti ficial sites created for c loning purpose). 
The result ing PCR product was digested with Bamffl and ClaI and c loned into the same 
sites of pcD A3, generating AG053 .  
Transfections  and I n fections  of Cells 
293T and Hela T4 cel ls were maintained at 37 °C in Du lbecco ' s modified Eagle ' s  
medium (DMEM) supplemented with 1 0% FBS and 7% calf serum, respectively, from 
Hyclone ( Logan, UT) . 293T cel ls were transfected using the calcium phosphate method 
as described in Mustafa et a l . ,  2005. Bliefly, the cel ls  were plated into 6-wel ls  plates at a 
concentration of 4 x 1 05 cel ls per \ el l  a day before the transfection. The next day, media 
was changed 2 hours before the start of transfections. A DNA cocktail was prepared with 
3 )lg of each DNA in the case of transfections with three plasmids, and around 4.5 )lg of 
each DNA in the case of two plasrnids. As a control for transfection efficiency, the firefly 
l uciferase expression vector, pGL3 control (Promega, Madison, WI) ,  was used at a 
concentration of 250 nglwel l .  P lasmid DNA was di l uted in  a DNA cocktail buffer (250 
mM CaCh 1 50 mM NaCI ,  1 0  mM Tris-CI ,  pH 7 .4, and 1 mM E DTA) and calc i um 
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phosphate precipitate \ as fonned using the 2 Transfection Buffer (50 mM HEPES, 1 80 
mM a 1 , 4 mM sodiwn phosphate, pH 7). The prec ipitate was formed by adding the 
o A cocktail to the 2 Transfection Buffer whi le bubbling, fol lowed by vortexing and 
incubation at room temperature for 30-40 mjnutes. After the incubation, the precipi tate 
\vas added to the 293T cel l s  and incubated for 4 hours at 3rc. Transfections were 
stopped by washing the cel ls twice with PBS, fol lowed by the addition of fresh media .  
The media was changed the next day and lowered to 1 . 5 m1 per wel l .  In case of 
infections irus released in the supernatants was harvested 72 hours post transfection and 
used to infect HeLa T4 cel ls using DEAE Dextran ( 1 0  mglml) .  Hygromyc in resistant 
colomes were selected for 1 0- 1 2  days, stained with crystal violet dye, and counted 
( Browmng et a I . ,  200 1 ) . 
L uciferase Assays 
To determine the transfection efficiency in the transfected cultures a portion of the cells 
were used to detect the luc iferase activity using the Dual-Luciferase Reporter Assay 
System ( Promega) and TW1ler TD-20e l urrunometer (Turner Designs, I nc .  Sunnyvale, 
CA). Briefly, transfected cel ls from a 6-wel l  plate were trypsimzed, washed once in  cold 
PBS,  and resuspended in 1 ml cold PBS .  One tenth of these cells were used to prepare 
cel l  lysate using 1 00 j...ll of I X  Passive Lysis B uffer (Promega). Cel l membranes were 
disrupted via three cycles of freeze/thaw (2 rrunutes in dry icel2 rrunutes in 37°C water 
bath) .  Cel l ul ar debris was pel leted via rnicrocentri fuging the lysates at 4°C for 5 minutes, 
fol lowed by transfer of the c larified lysates to new eppendorf tubes. A portion of the 
lysate was used subsequently in the luc iferase assay using 25 j...l l of the LAR I I  reagent 
5 1  
pro\ ided in the kit . The luciferase readings were perfonned using a 5 seconds delay and 
20 seconds integration time. alues obtained from the l uc iferase assay were normalized 
to the amount of protein used and these values were final ly  used to nonnal ize the alues 
obtained in the various assays including i Ills ti tration assay (colony forming units/rnl )  as 
\\ el l as packaging efficienc ies ( absorption units) determined from the Southern blots. The 
protein concentrations in the lysates \ ere determined using the protein assay reagent 
( B ioRad, Hercules, CA). Briefly, 2 f.d of concentrated or 1 :  1 0 di lution of the cel l lysate 
was tested in the protein assay against a standard curve prepared from BSA ranging from 
o jlg to 1 6  jlg protein. 
Virus I solat ion 
The supernatants col lected from the transfected cel l s  were c larified away from the 
cel lu lar debris by low-speed centrifugation at 4000 rpm for 30 minutes . This was 
fol lowed by pel l eting the viral partic les by u l tracentrifugation using SW28 rotor at 
24,000 rpm for 2 hours at 4°C.  Viral pel lets were resuspended in 1 25 )1 1 of TN E  buffer 
CO mM Tris-Cl, pH7.4, 1 00 mM aCI, and 1 mM E DTA, pH 8 .0). One third (� 40 )l.J )  
was sa e d  for analysis o f  virus particles by Western blots, while the remaining two-thirds 
(- 80 jll )  was used to isolate viri on RNA using the Trizol LS reagent ( Molecular 
Research Center OH) .  
Nucleocytoplasmic Fract ion of Transfected Cel ls  
To isolate cytoplasmic RNA, 90% of the trypsinized transfected cel l s  were resuspended 
in cold diethylpyrocarbonate (DE PC)- treated RL buffer (50 mM Tris pH 8, 1 40 mM 
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aCl, 1 . 5 111M MgCb) supplemented \ i th 0.5 % P40 and incubated on ice for 5 
minutes to gently lyse the cel ls without disrupt ing the nuclei . The intact nuclei were 
gently spun down at 300X g for 2 minutes and 70% of the cytoplasmic fractions were 
careful ly moved to fresh eppendorf tubes containing 1 rnl Trizol reagent for subsequent 
R A isolation. 
RNA I solat ion 
ytoplasmic and viral RNAs were isolated from the transfected ce l l s  72 hours post 
transfection using the Tlizol Reagent ( In itrogen Life Technol ogies) .  Virions in TNE 
buffer were lysed in 500 II I of Trizol LS reagent containing 8 III of polyacryl (used as a 
carrier) prior to RNA isolation whi le  90% of the transfected cel ls  were l ysed in  1 ml of 
Trizol .  Briefly cytoplasmic or viral lysates in Trizol were incubated at room temperature 
for - minutes fol lowed by the addition of chlorofoTI11 and vigorous shaking for 1 5  
seconds and incubation at room temperature for 2-3 minutes. Phases were separated by 
centrifugation at 1 2000X g for 1 5  minutes, and 90% of the aqueous phase (c lear in 
colour) was transferred to fresh eppendorf tubes containing 500 III of  isopropanol to 
precipitate RNA. The RNA was precipitated by mix ing and incubating the tubes at room 
temperature for 1 0  minutes and centri fugation at 1 2000X g for 1 0  minutes to pel let down 
the RNA. The pel l ets were washed once with 70 % ethanol and centri fuged at 7500X g 
for 5 minutes . Pel leted RNA was resuspended in nuclease-free water, its concentration 
determined by spectrophotometry, and stored at -80 t i l l  further use. 
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RT-PCR 
2 . 5  Ilg of cytoplasmic or  one fi fth of viral RNA was D ased-treated using 2-3 units of 
ampl ification grade D ase I ( Invitrogen Life Technologies)  at 3 7° C for 1 hour. DNase 
was heat inactivated at 65°C for 1 0  minutes after the addition of EDT A to 2 .5  mM. One 
II I of the D ased RNAs were tested in PCRs using hygromycin-specific primers (Table 
I 1 . 1 )  to confirm the absence of D A prior to cD A synthesis. This was fol lowed by 
cD A synthesis by first denaturing the RNA in the presence of  dNTPs and random 
hexamer primer for 5 minutes at 65°C, fol lowed by quick cooling on ice for 5 minutes. 
After spinning the components to the bottom of the tube, cDNAs were made by using 
reverse transcription reactions set up with 1 00 units of Moloney Murine Leukemia virus 
reverse transcriptase ( In itrogen L ife Technologies) in the presence of 40 units of RNa sin 
RNase Inhibitor ( Promega) for one hour at 42 °C .  cD As were ampl ified using the 
SuperMix PCR cocktai l ( Invitrogen Life Technologies) supplemented with additional 
gCb or Taq polymerase (Appl ied B iosystems, Cal i forn.ia, USA). The PCRs for 
unspl iced actin v,'ere perfoTI11ed as a multiplex in the presence of primer competimers for 
1 8  S ribosomal RNA as a control for cDNA addition ( 1 8S Quantum competimer control,  
Ambion, TX). 
PCR reactions were performed for 20-30 cycles at various annealing temperatures 
depending upon the melting temperature of the primer set used. The reactions were 
performed using the Perkin-Elmer 9700 thermo cycler with M icroArnp tubes. Products of 
PCR were analyzed on 2-4% agarose gels in the presence of  ethidium bromide. The gels 
were photographed and scanned using the B iometra gel documentation system (Whatman 




Table  I L l :  P ri mers u sed i n  RT- P C R  a n d  PC Rs 
-- --
Primer 
name Seq u e n ces 
OTR366 (+) 5 '  CGGCACTTTGCA TCGGCC 3 '  
OTR367 (-)  5 ' CGGCGATCCTGCAAGCTC 3 '  
OTR537  (+) 5'  CATGTTTGTGATGGGTGTGAACCA 3 '  
OTR538 (-)  5 ' GTTGCTGTAGCCGTATTCATTGTC 3 '  
OTR580 (+) 5 '  TGAGCTGCGTGTGGCTCC 3 '  
OTR58 1 ( - )  5 ' GGCATGGGGGAGGGCATACC 3 '  
OTR 582 (+) 5'  CCAGTGGCTTCCCCAGTG 3 '  
OTR600 (+) 5' GAACCCTGTCGAGTATC GTG 3 '  
OTR60 1 (-) 5' CTGGTTGCTGACTAATTGAG 3 '  
OTR660 (+) 5 ' GAGGACTTTTGAGTTCTCCCTTGAGGC 3 '  
Desc ription 
nl 423-440, hygromycin gene 
nt 1 0 1 0-993 hygromycin gene 
nl 983 - 1 005 of GAPDH 
nt 427-405 of GAPDH 
Spliced actin mRNA-speci fic  primer (S) (Tan et al . ,  1 995) 
Spl iced or unspliced actin mRNA-speci fic primer (A) (Tan 
et a l . ,  1 995) 
Unspl iced actin mRNA-speci fic primer (s- l )  (Tan et a I . ,  
1 995)  
n t  286 - 306 of F IV 5 '  LTR 
nt 1 840- 1 82 1  of pCDNA3 or nt 244 -263 of TAR SV 40 




OTR 459 (-)  5 '  aaaaaagcggccgcACTGCGAAGTTCTCGGCCCGG 3' * FlY nt 357-337 ( immediately before pbs). 
OTR 467 (+) 5 '  aaaaaagcggccgcGTTGGCGCCCGAACAGGGACT 3' * I1t 356 376 of flY 34TFI 0 """I 
.... 
OTR662 (-)  5'  AGCAGGAGTTCTGCTTAACAGCTTTC 3 '  * nt 440-4 ] 5 of FlY .... 
OTR627 (+) 5' TGGGATGAGTATTGGAACCC 3 '  nt 1 -20 o f  Fry Petal uma 5 '  L TR """I 
OTR5 1 7  (-)  5 '  gggcccaaattcgaaCTCGAAGTTTCACAAAGCACTGGT 3' * nt 9335-93 1 2  of FlY 34TF I 0  3 '  LTR 
.... 
OTR574 (+) 5' aaaaaagcggccgcATGGGGAATGGACAGGGGCGA 3' * nt 628-648 of F lY gag .... 
OTR503 (-) 5' aaaaaagcggccgcTCCCTTCTCCAAA TTTTTTACTCTTCC 3' * nt 727-70 1 of FlY gag � 
OTR 5 1 6  (+) 5' ticgaatttgggcccGAGTCTCTTTGTTGAGGACTTTTG 3 '  * nt 9336-9359 of  F lY 34TFl 0 3 ' LTR .... 
OTR460 (-) 5' aaaaaagcggccgcAAGTCCCTGTTCGGGCGCCAA 3' * nt 377-357 of F lY 34TF I 0  � 
-� 
F lY  sequences are shovvn in uppercase whi le  lowercase denotes sequences lIsed for clon ing purposes 
90 bp Probe 






blot analysis. The primers used in the PCR ampl ifications are l isted in Table 1 1 . 1 .  
Southern Blot Analysis 
The gels designated for Southern blotting were prepared for capi l lary transfer overnight 
in 20X C (3 1 aC1J0.3 M sodium ci trate) by denaturation (2X for 20 minutes at 
room temperature in 1 . 5 M aC1J0 .5  NaOH)  and neutral ization (2X for 20 minutes at 
room temperature in 1 . 5 M aC1J0.5 M Tris-CI )  using H ybond N+ membranes 
(Amersham B iosciences, UK). The next day the membranes were cross-l inked at 70,000 
micro-joules (UV crossl inker B L  254, Life Technologies) and hybridization performed 
by using the AlkPhos Direct Label ing Kit (Amersham, Arl ington H eights, I L) .  Probes for 
hybridization were generated by PCR ampl ification and gel purification of  the probe 
fragment (Qiagen gel extraction ki t, ) fol lowed by their quantitation on agarose gels. The 
D A fragnlents were labeled with alkaline phosphatase as spec ified in the kit . Briefly, 
rO-300 ng of  purified DNA fragment was boiled for 5 minutes in a v igorously boi l ing 
water bath and snap frozen on ice for 5 minutes. Denatured DNA was spun down by brief 
(5  seconds) microcentrifugation and conj ugated to alkal ine phosphatase as per 
manufacturer's directions. The blots were prehybridized at 55°C in a pre-warmed 
hybridization buffer for 30 minutes to 1 hour fol lowed by addition of extra hybridization 
buffer containing the probe. B lots were hybridized overnight at 55°C with gentle shaking, 
washed twice at 55°C with primary wash buffer ( 2M urea, 1 % S DS, 50mM Na phosphate 
pH 7.0, 1 50 mM aCL, I mM MgCh, 0 .2  % blocking reagent), for 1 0  minutes and twice 
at room temperature with I X  secondary wash buffer (0. 1 M Tris base, 0.2 M NaCI, pH 
1 0 .0) for 5 minutes and developed using the COP-Star chemilurninescent detection 
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reagent. The blots were exposed to Fuj i  Medical X-ray film (HR-G30, Germany) for 
various lengths of times, digit ized using the Biometra gel documentation system 
( \Vhatman Biometra, Gottingen, Germany), and analyzed for optical densiti es using the 
BioDoc Analyze software version 2 .0 .  
Western Blot Analysis 
iral proteins were anal yzed by Westem blot analysis using a polyclonal antisera (QB2 
fraction) from cats infected with the Peta luma strain of FIV (kindly provided by Dr. El len 
Col l i sson, Texas A&M University, Col l ege Station, TX) . Briefl y  virus partic les in the 
TNE buffer were l ysed in an equal volume of 2X SDS buffer along with 
betamercaptoethanol (�-me) boi led for 4 minutes, and loaded onto 8% SDS­
polyacrylamide gels. The proteins were electrophoresed at 1 20 V for 1 hour and 45 
minutes and transferred overnight using wet h'ansfer buffer onto Hybond-P membranes 
(Amersham, B iosciences). The fi lters were b locked for one hour at room temperature in 
5°'0 dried mi lk ( Regi lait, 0% Fat, France) in 1 X PBS-O. I % Tween buffer, fol lowed by 
incubation in the polyclonal primary antibody QBT2 ( 1  :2 ,500 di l ution in PBS-Tween- l % 
milk) for 1 hour at room temperature. The blots were then washed three times in PBS-
0. 1 % Tween for 5 minutes each, fol lowed by incubation in the secondary antibody (goat 
anti-cat H RP )  at 1 :  1 0,000 dilution for 1 hour at room temperature. The blots were washed 
three times using PBS-O. I % Tween buffer and developed using the Super S ignal  West 
P ico Chernilurninescent Substrate kit ( PIERCE, Rockford, I L) and exposed to Fuj i  
Medical X-ray fi lm for various lengths of time. 
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Secondary RN A  Structu ral Ana lysis 
The [olding potential of  the various FrV sequences studied was tested by using the RNA 
structure sequence analysis so[(\ are (version 3 .6) (Mathews et a! . 1 999) that uses 
algOIi thms based on free energy minimi zation to predict the secondary RNA structure. 
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Chapter III 
RE SULTS & DISCUSSION I 
Role of eq u ences i n  bet'ween the core packagi n g  determi n a n ts i n  Fl V RNA 
packagi n g  
Our previous deletion analysis studies ha  e re ealed the presence of two core sequence 
elements within the 5 '  end of the FlY genome that contribute significantly to FlY RNA 
packaging ( Fig. I l L  1 ) . The first region consists of sequences from the start of the FlY 
transclipt in the 'R" region to within the first � 1 20 bp of 5 UTR and the second region 
consists of the first 1 00 bp of gag (Browning et a I . ,  2003 a & b) .  However, it has not been 
clear what was the contribution of sequences in between these core elements towards 
packaging. Were these sequences completely dispensable or perhaps necessary to 
maintain any putative secondary RNA structure that the core region may fold into. 
Therefore starting with our previously defined control vector, MB 1 5  ( Fig. l I I . 2) ,  that 
contains the R1U5,  the entire 270 bp of the 5 '  UTR, and 1 00 bp of gag, we generated a 
new series of  transfer vectors, AG002-AG004, that maintained the RJU5 and 1 00 bp of 
gag, but kept onl y the first 90,  1 20 or 1 50 bp of the 5 '  UTR, thus generating deletions of 
1 80, 1 50, and 1 20 bp,  respectively, between the core packaging determinants ( Fig. l I I .2). 
In a second series of vectors, AGO 1 3 -AGO 1 5  the deletions were replaced with 
heterologous sequences of  same lengths from an expression vector, pcDNA3, to further 
determine whether the deleted/substituted region had a role  at the structural level, perhaps 
as a spacer ( Fig. I I I .2 ) .  
The two series of deletion and deletion/substitution vectors were tested for their 
abi l ity to be packaged by the f lY proteins using our in vivo packaging assay ( Fig. I I I . 3 )  
(Browning e t  a 1 . ,  200 1 ) . B riefly, the assay consisted of MB22,  a packaging construct that 
provides the f lY  gag/pol structural proteins and MD.G,  a YSY-G Env expression 










































1 00 bp gag 
Figure 1 I 1 . t .  Two discontinuous regions define the core packaging determinants of F l Y. The fi rst 
region consists of sequences from the start of the f l Y  transcript in the .oR" region to within the first 
- 1 20 bp of 5 '  UTR and the second region consIsts of the fi rst 1 00 bp of gag (Browning et a l . ,  2003 
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Figure I l I .2 .  Test of the region mtervening the core packaging determinants for effects on packaging. Schematic 
representatlon of A) complete F l Y  genome, B) M B 1 5 , the control transfer vector, C) two core e lements required 
for efficient A packaging. The arrow encompasses the sequences in between these two core element, and D) 
transfer vectors wah deletlons behveen the two core elements (AG002-AG004) and vectors with s imultaneous 
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Fi g u re I I ! .3 .  Design of the In vivo packaging assay. RNA expressed from the transfer vector is the 
packageable Ri'lA because it contains the packaging signal , \jJ, and the hygromycin  resistance gene as a 
selectable marker. The GagIPol packaging construct expresses the structural proteins, and the Env 
expre sion construct expresses the vesicular stomatit is glycoprotein (VSV -G) necessary for v i ral 
part ic les to infect cells expressing the corresponding receptor. The three plasmids are transfected 
together in the " producer" 293T cel ls that generate the "helper free" v i rus stocks conta in ing the transfer 
\'e tor RNA which is then used to infect target cel ls. S ince these v i rions have only the transfer vector 
R.l A as the genome, they are deficient for further rounds of repl ication, result ing only in a single round 
of repl ication. The successfu l ly infected cells are selected by the use of hygromycin and the 
hygromyc in-resistant colonies obtained are proportional to the v i rus titer . 
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plasmid that provides the env glycoproteins. Together, the two plasnuds express the 
structural genes necessary for the formation of the virus particle .  The transfer vectors 
pro\ ided the packageable RN s with various deletions or insertions in the packaging 
s ignal . In addition, they carried the SY-Hygro cassette as a marker gene and a clUmeric 5 '  
FI  L TR \vhere the U3 had been replaced by the hCMV to ensure successful function in 
human cells (Poeschla et a1 .  1 998a; Browning et aI . ,  200 1 ) . Additional ly, the transfer 
vectors contain the 3 '  F lY LTR for transc11pt termination as wel l  as successful reverse 
transcl1ption and integration and the M PMV CTE necessary for efficient 
nucleocytoplasmic transport of the transfer vector RNAs (Bray et aI . ,  1 994' ZolotuklUn et 
aI . ,  1 994; Browning et aI . , 200 1 ) . 
The region i n  between t h e  two core packagi n g  determi n a n ts is n ot necessary for 
packagi n g. The three-plasnUd trans complementation assay was used to test the ability 
of  the new series of transfer vectors to be packaged and propagated by flY partic les 
generated from MB22 . Each transfer vector was co-transfected with MB22 and M D.G 
into 293T ce l l s  along with a l uc iferase expression vector to monitor transfection 
efficiencies in the transfected cells. Yirus was harvested 72 hours post transfection and 
processed for vira l  RNA and proteins, as wel l as used to infect HelaT4 cel ls  to deternUne 
the transduction efficiency of the packaged RNA. The infected cel ls were selected with 
media containing Hygromycin B to ident ify successful ly transduced cel ls  by the presence 
of hygromycin resistant colonies 1 0  days post infection. The transfected 293T cel ls  were 
further fractionated into nuclear and cytoplasmic fractions for extraction of cytoplasnUc 
RNA to determine successful transport of transfer vector RNAs, whi le  whole  cel l  protein 
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extracts were isolated for determination of  transfection efficiencies. 
First we analyzed the amount of  transfer ector RNAs packaged into viral 
particles ( Fig. I I l A  panel ). TO\ ards this end RNA was extracted from two thirds of 
the pel leted virions, a portion of which was D ase-treated, reverse transcribed and used 
in PCR ampl ifications using primers across the RJU5 and SV40 promoter. Portions of 
the D ased RNA were tested by PCR to confinn the absence of plasmid DNA ( Fig. I l IA, 
panel A). To ensure that the ampli fications were in the linear range of  detection, PCRs 
were conducted for 20, 25 ,  and 30 cycles, the resul ting products were size fractionated on 
agarose gels, transferred onto nylon membranes, and hybridized with an RJU5 probe 
using a non-radioactive alkal ine phosphatase label ing method (see Materials and Methods 
for detai ls) .  The chemi l luminescent signals emitted were captured on X-ray fi lms for 
various lengths of  time and digitized using the B iomeh-a gel documentation system. 
As observed in Fig. I I l A  panel A al l  six of the transfer vector RNAs with either 
deletions or deletion/substitution of the sequences in between the two core packaging 
detenninants were packaged in the i rus partic les, however, with d ifferent efficiencies. 
This was despite the fact that the transfection effic iencies were within 2-fold of each 
other and al l  the cultures produced similar levels of viral partic les ( Fig. I l I A, panels B & 
C). Since the PCR was conducted across the deleted or deleted/substituted region, the 
size of the PCR fragment varied with each construct, confirming that the correct 
packaging constructs were being expressed in each transfection. 
To detennine the packaging effic iencies of the various constructs accurately, the 
PCRs were repeated using pri mers within the RJU5 region that was common to all the 
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Figure l l J .4. Analys is  of the relat ive packaging efficiencies of 
transfer vector RNAs with deletions and/or simultaneous insertions 
between the two core regions. A) Semi-quantitative RT-PCR of the 
iral cD A ampl ified using OTR600 (R primer)/60 1 (SY40 
primer) and probed with RlU5 probe. Bottom gel represents the 
DNase-treated iral RNA which was ampl ified using plasmid­
speci fic primer OTR 366/367 (hygro primer), +C, p lasmid as a 
positive control .  B) Western blot analysis of equivalent amounts of 
the remain ing one fourth portion of puri fied v i rus harvested from 
transfected cultures using the F l Y  antiserum from infected cats. C) 
Transfection efficiencies observed for di fferent constructs assessed 
by the luciferase acti ity from the co-transfected pGL3 D A using 
the Dual Luc iferase Assay kit. RLU, relative l ight units. 
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constructs. Once again, peR as conducted for 20, 25 ,  and 30 cyc les and Southern 
blotted, as described above. The optical densi t ies observed in the various bands obtained 
on X-ray fi lm were quanti tated using the Biometra gel documentation system and 
nom1alized to the amount of luc iferase expression observed in each of the transfected 
culture to take into account differences in transfection efficiencies. Fina l ly, the 
transfection efficiencies obtained were compared to MB 1 5 , the control transfer vector 
wi th R U , the ent ire 270 bp of the 5 '  UTR, and 1 00 bp of gag that was assigned a 
packaging efficiency of  1 to al low for an easy comparison between the different 
constructs. 
As shown in Fig. I l LS ,  panel A, the transfer vector RNAs with only 90 bp of the 
- , UTR AG002 and AG0 1 3 , were least efficiently packaged (0.23 and .06 respectively) 
when compared to MB 1 5 . The packaging efficiency increased substantial ly with the 
increase of 30 bp at the 5' UTR as observed for AG003 and AG0 1 4  that contain 1 20 bp 
of 5 'UTR (0.62 and OA, respectively), and increased to nearly the same as M B 1 5  by 
having 1 50 bp of  5 UTR, as seen for AG004 and AG0 1 5  (0 .8 and 0.92 respectively). 
These results are in agreement wi th our previous observations that sequences around 1 20 
bp of the 5 '  UTR are necessary for efficient RNA packaging and suggest that the 
deletions or deletions with simultaneous substitutions do not affect the packaging 
efficiency of FIV transfer vector RNAs substant ia l ly. Final ly, the packaging efficiency 
observed for MB 1 5  was comparabl e  to that observed for TR394 ( Fig.  I l IA) ,  the wild type 
transfer vector that contains not only the entire 5 '  UTR, but also 333  bp of gag 
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Figure 1 1 1 . 5. The region in  between the two core packaging 
determinants i s  not necessary for packaging. A) Semi-quantitative RT­
PCR of the v i ral cD A ampl ified using OTR 660/662 which gives the 
same size fragment and probed using the RlU5 probe. The relative 
packagi ng efficiency was calculated from average of ODs from 20 and 
25 cycles. B )  DNase-treated cytoplasmic RNA ampl i fied using 
plasmid-spec ific primer OTR 366/367 (hygro primer) +C, p lasmid as a 
posit ive control . C) Control for nucleocytoplasmic fractionation 
technique. The upper panel is the RT-PCR on cytop lasmic RNA for 
spl iced act in  which should be present i n  both the nuc lear and 
cytoplasmic fractions, whi le  the bottom panel is a mult ip lex RT-PCR 
for unspl i ced �-actin m RNA that should be exc lusively nuclear and 
1 8S ribosomal RNA as a control for the presence of cDNA. 
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TR only the first 1 00 bp of gag were necessary for efficient FIV RNA packaging 
( Browning et a1 . ,  2003a and b).  
It is possible that the results obtained above were due to poor expression, 
instabi l i ty, or defLcient nuc leocytoplasmic transport of some transfer vector RNAs. 
Therefore, similar to the viral RNAs, cytoplasmic RNAs were DNase-treated and 
confLnlled by PCR for the absence of contaminating DNA ( Fig. I l L S, panel B ). This was 
fol lowed by cD A preparation and PCR analysis of  the cytoplasmic cDNAs for 20, 2S ,  
and 30 cycles fol lowed by Southern blotting as  described above. As shown in Fig. I l LS ,  
panel A, a l l  the transfer vector RNAs were stably  expressed and efficient ly transported to 
the cytoplasm of the transfected cel ls .  
To ensure that our nucleocytoplasmic fractionation teclmique was rel i able, the 
cytoplasmic RNAs were tested by RT-PCR for the presence of unspliced (3-actin mRNA 
( Fig. I I I . S , panel C). orrnal ly, the unspl iced (3-actin mRNA is found exclusively in the 
nucleus unless the nuclear membrane integrity has been compromised (Tan et aI . ,  1 995) .  
As can be seen, only the spl iced (3-actin mRNA was observed in the cytoplasmic 
fractions ( Fig. I l L S, panel C, top half), while the unspl iced RNA was undetectable  with 
30 rounds of PCR eventhough. i t  could be picked up in the nuclear fraction ( Fig.  I lLS ,  
panel C, bottom half) .  To ensure that each cytoplasmic sampl e  in  the unspJ iced (3-actin 
PCRs contained ampl i fiable cDNAs, the unspl iced (3-actin PCR was conducted in the 
presence of primers for 1 8S ribosomal RNAs as an internal control ( Fig. I l LS ,  panel C, 
bottom half). 
The drastic effect on packaging observed for AGO 1 3  over and above the l ack of  S' 
UTR sequences is probably  due to the 1 80 bp heterologous sequences that were inserted 
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to maintain the spacing that any potential structural elements within the two core regions 
may assume. This 1 80 bp insertion, and in particular, the last 30 bp of it, seems to have 
destabi l ized the entire region since thei r removal (as in AG0 1 4  that contains only the first 
J 50 bp of the 1 80 bp insertion) re-stabi l ized the region for packaging to nearly the same 
extent as AG003 and AG0 1 4 (vectors with 1 20 bp UTR with or without 1 50 bp 
insertions, respectively). Other than AGO I 3 , the packaging efficiencies between the 
vectors with the internal deletions were simi lar to the vectors where the deletions had 
been replaced by the heterologous sequences, suggesting that the sequences in between 
the core packaging determinants were not needed as spacers ei ther and the core elements 
could fold into functional packaging determinants independently of the spacer region. 
Finally, the abi l ity of  the transfer vector RNAs to transduce the hygromycin  
marker gene to  target cel ls was determined by infecting HeLa cel ls with virions produced 
by the 293T cel ls .  Colony numbers observed upon hygromycin selection were adj usted 
to the amount of firefly  l uc iferase expression observed per microgram protein to 
normal ize for transfection efficiencies. Overa l l ,  the transfer vector RNAs were 
transduced to the target cel ls  with about 1 - to 4-folds reduced efficiency than the control 
vector, Jv1B 1 5  (Table i l L  I ) . Transfer vector RNAs with the 5 UTR deletions, AG002-
AG004 were propagated with � 2-3-fold reduced efficiency, whi l e  those with the 
deletion! insertions, AG0 1 3-AGO l S  were propagated with a 1 -4-fold reduction when 
compared to Jv1B 1 5  (Table I I I . 1 ). The vectors with only 90 bp of the 5 '  UTR (AG002 and 
AG0 1 3 )  exhibited the greatest reduction in t iters, probably  reflecting the poor packaging 
efficiency observed with these vectors (see Figs. I I I .4 & I 1 l . S ) ,  whi le  vectors with 1 20 
(AG003 and AG0 1 4) and 1 50 bp UTR (AG004 and AGO I S ), resul ted in near wild type 
7 1  
Table  1 1 1 . 1 .  T h e  i n te rve n i n g  region between t h e  core packagi n g  d eterm i n a n ts does not a ffect 
t l'a nsfer vector RNA p ropagat ion 
Vector 5'  UTR I gag H eterologo u s  LUC N o rm a l ized Fold P value 
n a m e  m a i n ta i n ed sequences added T i te r  (C FU/m l) Red uction « O.On 
AG002 90/ 1 00 - 7 1 3±68 3 . 1  0.000 1 
AG003 1 201 1 00 - 966± 1 23 2 .3  0.0056 
AG004 1 501 1 00 - 9 1 0±76 2 .4  0.0004 
AG0 1 3  901 1 00 1 80 588± 1 0 1  3 . 8  0.00 1 
AG0 1 4  1 201 1 00 1 50 1 ,208±9 1 1 . 8 0.000 1 
AG0 1 5  1 501 1 00 1 20 1 ,646±66 1 .3 0.002 
M B 1 5  2701 1 00 - 2,229± 1 8  1 .0 -
TR394 270/333  - 2 ,4 1 7±238  0.9 0.064 
Mock No DNA - < 1 - -
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ti ters (within 1 -2-folds) ei ther with or without the insertions, reflecting the improved 
packaging efficienc ies observed with these ectors. 
truct u ral  a n a lysi o f  the fol d i ng potent ia l  of the 5' end of the F I V  genome a n d  i ts 
correlat ion w i t h  t h e  packaging efficiency data  
To detemune ho\ the folding of the spacer region in between the two core determinants 
was affected by the deletions or deletion/insert ions, the regions between R and end of 1 00 
bp gaa of our arious mutant vectors was folded using the RNAstructure (version 3 .6) of 
Zuker and col leagues that uses energy mininlization algorithms to predict foldings of 
RNA molecules ( Mathe\\'s et aI . ,  1 999). Folding of tbis region in TR394 and M B 1 5, the 
control vectors with the entire 270 bp UTR and either 333 or 1 00 bp of gag, revealed the 
presence of four stem loops (SL l -4)  in U5/5 ' UTR region start ing from about 20 bp into 
the U5 to about 6 bp downstream of the major spl ice donor, mSD ( Fig. I I I .6, panels A & 
B) .  These stem loops seemed very stable since they were perfectly conserved in the four 
predicted structures in TR394 and the two predicted structures in M B 1 5 . Furthermore, 
the major spl ice donor in each case was downstream of the four stable  stem loops and 
formed part of the stem that completed the folding of the stably  folded region confirming 
the prior functional analysi s that revealed that sequences downstream of  mSD and 
upstream of gag did not contribute to packaging (see Fig. I I I .6)  ( B rowning et aI . ,  2003a).  
S L2 is poten t i a l l y  the  key packagi n g  determi n a n t  of FIV. Folding of  the vectors 
RNAs containing the incremental deletions or delet ions with insertions revealed that most 
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Figu re U 1 .6. The fold ing potential of the mutant transfer vectors either with deletions or 
deletions/insertions in between the two core elements. The ovals represent the conserved 
stem loop structures, SL l -4 .  The emerging SL2 loop observed in AG003/ AG004 and 
AGO 1 41 AGO 1 5  is highl ighted by the arrows with the knobs at the end. 
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the vectors \vith on ly 90 and 1 20 bp of the UTR except for the smal l  stem loop SL I that 
was observed in the US of a l l  the RNAs folded ( Fig. I I I .6, panels C-F) .  However, in the 
presence of 1 20 bp of UTR, the first fe'> loops of  SL2 started to emerge in AG003 and 
1 4 , whi le  in the presence of the I SO bp UTR, 2/3rd of the large S L2 observed in TR394 
and MB 1 5  had ref0Il11ed ( Fig. I I I .6, panels G & H) .  The emergence of partial stem loop 
2 in the vectors \\l ith 1 20 and 1 50 bp deletions ( i lTespective of the presence or absence of 
the insertions) suggests that the first 2/3rds of  SL2 may be the major packaging 
detem1inant 0 f FI since a signi ficant restoration of packaging was observed in vectors 
\ ith 1 20 bp UTR, whi le the packaging was nearly at the wild type l evel with 1 50 bp 
UTR ( Fig. I l LS ) .  Furthem1ore, cOlTelation of our packaging data with the stmctural 
analysis also suggests that S L I  present in the US region does not play a sign ificant role  as 
the packaging detenmnant in FrY since drastic reductions in packaging were observed 
with AG002 and AG0 1 3 , the vector RNAs that sti l l  maintain S L I  ( Fig. I I I .6 ,  panels C & 
D) .  
These results are contrary to  the findings of  Kemler e t  a I . ,  (2002) who mutated 
what encompasses the fourth looplbulge and stem region of SL2 predicted by our 
computer analysis ( Fig .  I I I .6 ,  panel A) .  In their stmctural analysis this region formed a 
small independent stem loop that had a s imi l arity to the stem loop 3 (SL3 )  of H IV- 1 the 
main packaging detenmnant of H IY - 1 that binds the nucleocapsid protein ( Berkowitz and 
Goff, 1 994; Berglund et a I . ,  1 997; Lochrie et a I . ,  1 997) .  H owever, their stem loop 
abrogating mutations did not affect FrY RNA packaging. One reason for the contrary 
findings could be that the first three bulges/stems of SL2 may be the main detenmnants 
of F lY RNA packaging, which should not have been affected by their mutations (Fig. 
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I I I .6,  panel ). This speculation is supp0l1ed by the observation that maintenance of 1 20 
bp UTR in AG003I AGO 1 4  resul ted in the appearance of the first two of the bulges/stems 
of  L2  that restored � 50 % of  the packaging potential of transfer vector RNAs ( Figs. I I I .  
and I l l .  6, panels E & F) .  Thus, F IV may not need the entire S L2 for packaging, but 
only the first part of th is structure that is probably sufficient ly  formed by the presence 
> 1 20 bp in the UTR, but < 1 50 bp. 
Interestingly, the gag region ( 1 00 or 333 bp) in the control vectors did not fold 
into any particularly consistent stem loop structure. Either our analysis was not stringent 
enough to pick up any signature folding patterns, or gag may not necessari ly  be involved 
at the structural l evel .  Since the functional data demonstrates that gag sequences are 
critical for packaging, the RNA folding data suggests that sequences in gag may help Fry 
differentiate behveen genomic and sUbgenomic mRNAs prior to packaging by providing 
intronic sequences to the packaging signal . Or, i t  is  possible that sequences in gag may 
provide a more indirect role simi lar to that observed in H IV-2 related to a co-translational 
mechanism for ident ifying genomic mRNAs for encapsidation. 
In  short, using a combination of mutational analyses and computer predictions 
studies presented in this part of  the thesis c learly demonstrate that the Frv packaging 
determinants are found as two core discontinuous regions at the 5' end of the viral 
genome. The first of these regions ( RlU5 + 1 50 bp UTR) is present upstream of the 
major spl ice donor and folds into a complex stem loop structure, whi le sequences in the 
first 1 00 bp of gag also contribute crit ical ly to the abi l ity of the virus to recognize the 
genomi c  message from the plethora of cel lul ar and spl iced mRNAs. 
These results are in  partial agreement with those of  Kemler et a I . ,  2002 and 2004 
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who found that the RJU5 region (in particular), but also the 1 54 bp of the UTR harbored 
the main packaging detem1inants of FI , and simultaneously required help from the first 
- 90 bp of gag. ince al l  our vectors contained RJU5,  we could not d ifferentiate between 
the relat i  e contlibutions of ectors with and without RJU5 to packaging. However, 
based on the analysis of the structural data, our studies suggest that probably  the main 
packaging detemunant wi l l  l ie  more within the first 1 50 bp of the UTR than the RlU5 
sequences. 
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C h apter IV 
RESUL,TS & DISCUSSION II 
Role of 5 a n d  3 '  LTRs on the  packaging effi ciency of F lY  RNA. 
Results presented in Chapt r I I I  c learly show the discontinuous and multipartite nature of 
the FI packaging detenninants, reveal ing at least n�o regions of the FlV 5' end that 
sign i ficantly affect FlY RNA in packaging. Howe er our earlier mapping studies had 
implicated other regions of the F l  genome towards packaging, including the 3 '  LTR 
( Browning et al. 2003 a &b). In addition, studies publ ished around the same time also 
pointed to the role of 5 '  RfU5 sequences as being actual ly  the primary packaging 
detemrinant ( Kemler et al. 2002 & 2004). Since all our previous studies did not 
di fferentiate between the 5 ' UTR and the R/U5 region and were done in the presence of 
the 3 '  LTR, we wanted to detemline the relative conh'ibution of  the FLY 5' and 3' L TRs 
to FlY RNA packaging. 
To\ ards this end, we uti l ized a wo-plasmid trans complementation assay that 
consisted of a packaging construct and a series of transfer vectors. Unl ike the 3-plasmid 
system, this assay l acked the vector that would provide the envelope proteins since there 
was no need for the infection of target cel ls as most of the transfer vectors l acked the 
sequences necessary for reverse transcription integrat ion and propagation into the target 
cel ls .  The transfer vectors contained various port ions of the putative FlV packaging 
signal expressed from the hCMV promoter for transcript initiation and the BGH poly A 
signal for transcript termination. 
RfU5 region i n c reases the packagi n g  efficiency of heterologo u s  F IV  transfe r  vector 
RNAs. To determine the role  and contribution of the 5' R/U5 region to packaging, the 
expression vector pcDNA3 was modified to generate a series of transfer vectors that 
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contained the two core packaging determinants of FIV ei ther in the presence or absence 
of RI 5 in the non-viral heterologous context ( Fig. IV. I ,  panel A) .  To ensure that we had 
the entire core region, we maintained either 90, 1 20, or 1 50 bp of the 5 '  UTR and the first 
1 00 bp of gag. AG026, AG02 7, and AG028 are transfer ectors that contain the core 
packaging determinants in the presence of RlU5 ,  whi le AG040, AG04 I ,  and AG042 
contain only the core packaging determinants ( Fig. IV. I ,  panel A) .  Since we were testing 
such smal l  parts of the FlV genome, the - 2 kb SV -Hygro cassette was inserted in the 
transfer vectors to increase the size of the packageable RNAs and make them rel atively 
the same size for easier relative comparison. 
As stated earl ier, each transfer vector was co-transfected with M B22 into 293T 
cel l s, virus was harvested 72 hours post transfection and processed for RNA and proteins, 
whi le a portion of the tTansfected cultures were fractionated into nuclear and cytoplasmic 
fractions for iso lation of cytoplasmic RNA. To monitor for variations in transfection 
efficiencies, the luc iferase expression vector pGL3 Control ( Promega), was also included 
in the D A cocktai l  and a portion of  the transfected cul tures was used to determine 
l uc iferase expression . 
First, the expression of the transfer vector RNAs in the transfected cultures was 
analyzed to determine if the vector RNAs were expressed and efficiently transported to 
the cytopl asm. Towards this end, equal amounts of the cytoplasmic RNA from each 
transfected culture was DNase-treated, reverse tTanscribed, and PCR ampl ified using 
OTR 467/0TR503, primers within the PBS and the gag region ( Fig. IV. l ,  panel B). As 
shown, a11 transfer vector RNAs were expressed efficient ly in the cytopl asm of the 
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Figure IV. l .  Test of the F IV R!U5 region towards contribution to flY RNA 
packaging. A) Schemat ic representat ion of the transfer vectors with/without the RlU5 
region in addition to the two core regions in heterologous context . B) RT-PCR of 
cytoplasmic cD A amplified using OTR467 (pbs) and OTR503 (gag). The bottom gel 
shows the D ase-treated cytop l asmic RNA which was ampli fied using plasmid 
speci fic  primer OTR366/367 (hygro primer), +C, p lasmid as a posit i ve control .  C) 
Control for nucleocytoplasmic fractionation technique. The upper panel is the RT-PCR 
on cytoplasmic RNA for spl i ced act in which should  be present in  both the nuclear and 
cytoplasmic fractions, whi le  the bottom panel is a mult iplex RT-PCR for unspl iced P­
act in  m RN A  that should be exc lusively nuc lear and l 8S ribosomal RNA as a control 
for the presence of cD A. D) Transfect ion efficiency observed for d ifferent constructs 
assessed by the luciferase activity from the co-transfected pGL3 DNA using the Dual 
Luc iferase Assay kit .  RLU, relative l ight units. 
8 1  
successful ly  transported out of the nucleus and into the cytoplasm. S ince we amplified 
across the -
, 
UTR, the size of the PCR fragment di ffered between the d ifferent constructs 
and was indicative of the particular transfer vector used for transfection. As a control ,  a 
portion of the DNase treated RNA was tested by PCR using plasmid-specific hygromycin 
primers to monitor for D contamination. Al l the samples were negative (except for 
the plasmid D A sample that acted as a positive control ,  see l ast lane), assuring that 
there was no D A contaminating our RNA samples ( Fig. IV. I ,  panel B) .  
To ensure that the nucleocytoplasmic fractionation techni q ue was effective, the 
cytoplasmic RNAs were tested for the presence of the unspl iced f3-actin rnRNA by PCR. 
As mentioned earl ier, unspliced f3-actin mRNA i s  found exc lusively within the nucleus, 
while the spl iced fonn is found both in the nucleus and the cytoplasm (Tan et aI . ,  1 995 ) .  
As can be seen, spliced f3-actin rnRNA was abundantly found in the cytoplasm ( Fig. IV. I ,  
panel C, upper half), whi le the unspl iced f01111 was completely absent fon11 the 
cytoplasmic portion ( Fig. IV. I ,  panel C, lower half) ,  and present ool y in the nuclear 
fraction ( last l ane) .  The unspl iced f3-actin PCR was conducted in the presence of 1 8S 
ribosomal RNAs primers which acted as an internal control for the presence of  
amplifi ab le  cD As in each sample ( Fig. IV .  I , panel C, lower half).  
Once confinned that a l l  transfer vector RNAs were effic iently expressed and 
transported to the cytoplasm, we went on to analyze the amount of RNA packaged into 
the actual v irus particles.  S imilar to cytoplasmic RNAs, the vira l  RNAs were DNase 
treated, reverse transcribed and used in PCR ampl ifications. To make sure that the 
amplifications were in the l inear range of detection, PCRs were conducted for 20, 25, and 
30 cyc les the resulting products were run on agarose gels, transferred to nylon 
82 
membranes and hybridized with an F lY gag probe using a non-radioacti e alkal ine 
phosphatase label ing method (see Materials and Methods for detai ls) .  The 
chemil luminescent signals emitted were captured on X-ray fi lms that were digitized and 
the optical density in the various bands quantitated using the B iometra gel documentation 
system. Final ly, the optical densities obtained were normalized to the amount of 
luc iferase expression observed in each of the transfected culture to take into account 
differences in tmtlsfection efficiencies. 
As observed in Fig. IY.2, all transfer vector RNAs were packaged, but to various 
extent. The constructs with the R/US region (AG026-028) were packaged more 
efficiently showing relati e packaging efficiencies ( RPE) of 3 .2, 6 and 1 0  than those 
l acking the RlUS region (AG040-042)  displaying rel ative packaging efficiencies of 1 ,  3 . S  
and 2 .7 .  This i s  despite simi lar transfection efficiencies ( Fig. IV. I ,  panel D)  and the 
production of s imilar levels of viral part ic les in the transfected cultures ( Fig. ry .2) .  In 
agreement with our previous results, the deletion construct with only 90 bp of UTR was 
packaged least efficiently ( RPE of 3 .2), fol lowed by the construct with 1 20 bp UTR ( RPE 
of 6), whi le  I SO bp UTR enhanced packaging the most ( RPE of 1 0) .  Together, these 
results reveal that efficient packaging by FIV proteins requires at most I SO bp of the S '  
UTR i n  the presence of  1 00 b p  o f  gag, and this level o f  packaging can b e  nearly doubled 
or more by the presence of R/US sequences at the S '  end. 
Role of the 3' L T R  on t h e  packaging efficiency of F I V  RNA. To study the role of the 
3 '  L TR, three new transfer vectors were constructed. AG030 and AG03 1 represent 
transfer ectors that express the entire 270 bp UTR either in the presence or absence 
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Figu re J .2 .  The RlU5 region increases the packaging 
efficiency of heterologous FLY transfer vector RNAs. Semi­
quantitative RT-PCR of v iral cD A ampl ified using 
OTR467 (pbs) and OTR662 (90 bp of 5' UTR) for 20, 25 
and 30 rounds of PCR and probed usi ng the 90 bp probe. 
The panel below shows the D ase-treated viral RNA which 
were ampl i fied using plasmid specific  primer OTR366/367 
(hygro primer). The bottom panel shows the Westem blot 
analys is  of equivalent amounts of the remain ing one fourth 
purified v i rus harvested from transfected cultures using the 
flY antiserum from infected cats. The relat ive packaging 
efficiency was calculated from a erage of ODs from 20 and 
25 cycles. 
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or R U - sequences, while MB 1 5  and AG039 contain the entire 270 bp UTR either in the 
presence or absence o[  R/U5,  respectively, but with the 3 '  LTR for transcript termination 
( Fig. I . 3 ,  panel A). 
Tlte 3 '  L TR cOlltribute to FI V RNA packagillg. The [om constructs were tested in our 
packaging assa as described before. Al l  constructs were efficiently expressed in the 
cytoplasm of the transfected cel l s  ( Fig. IV.3,  panel B) .  These cytoplasmic RNA extracts 
were fractionated appropriately since no unspl iced �-actin mRNA could be observed in 
the cytoplasm(Fig. IV.3 ,  panel C), and no amplification could be observed when the 
D ased RNAs were used as template in PCR reactions with hygro primers ( Fig. IV .3 ,  
panel B) .  Final l y, semi-quantitative RT-PCR analysis of  the RNA packaged in the 
virions revealed that the vectors without the 3 '  LTR, AG030 and AG03 1 were packaged 
with 5- and 3-fold less efficiency than their counterparts with 3 '  LTR, M B  1 5  and AG039, 
respectively ( Fig. IV.4) .  These results were confrrmed using an independent primer pair 
(data not sho\\11) .  These constructs also confirmed om earl ier results that RlU5 increased 
the packaging efficiency of vector RNAs by � 2-3 -folds despite the presence of the entire 
5 '  UTR (compare AG030 with AG03 1 and MB 1 5  with AG039) ( Fig. IV.4) .  This was 
despite the fact  that a l l  vectors were transfected with simi l ar effic iencies ( Fig. IV .3 ,  panel 
D) and similar amounts of virions were produced in each cul tme ( Fig. IV.4) .  
Taking this  analysis further, two more transfer vectors were constructed to 
determine whether 3 '  L TR could enhance the packaging efficiency of transfer vector 
RNAs in the absence of the 5 '  UTR. AG02 1 and AG029 contain the F IV RJU5 region at 
the 5 '  end and either the BGH poly  A signal or the 3' FIV LTR downsh·eam of the SV-
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Figure IV .3. Test of the 3 '  LTR and RlU5 regions towards contribution to F l Y  RNA 
packaging. A) Schematic representation of the transfer vectors with/without the 3' 
L TR and RlU5 region in  the presence of the enti re 270 bp of 5' UTR and 1 00 bp of  
gag. B) RT-PCR of cytoplasmic cD A ampl ified using OTR467 (pbs) and OTR503 
(gag). The bottom panel shows the D ase-treated cytoplasmic RNA which was 
ampli fi ed using p lasmid  specific primer OTR366/367 (hygro primer). +C, p lasmid as a 
posit i  e control .  C) Control for nucleocytoplasmic fractionation techn ique. The upper 
panel I S  the RT-PCR on cytoplasmic RNA for spl iced actin  which shou ld  be present in  
both the  nuclear and cytoplasmic fractions, whi l e  the  bottom panel i s  a mUl t iplex RT­
PCR for unspl i ced �-actin  mRNA that should be exclusively nuc lear and 1 8S 
ribosomal RNA as a control for the presence of cDNA. D) Transfection efficiency 
observed for d ifferent constructs assessed by the l uc iferase act iv i ty from the co­
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Figure IV.4. The 3 '  LTR and RlU5 region 
i ncrease the packaging efficiency of F IV transfer 
vector RNAs. A) Semi-quantitative RT-PCR o f  
v i ra l  cD A ampl i fied using OTR467 (pbs) and 
OTR503 (gag) for 20, 25 and 30 rounds of PCR 
ampl ification and probed using the gag probe. The 
below panel shows the DNase-treated v iral RNA 
which was ampl i fied using p lasmid spec ific 
pnmer OTR366/367 (hygro primer). +C, plasmid 
as a posi t ive control .  The bottom panel shows 
Western blot analysis of equivalent amounts of 
the remaining one fourth purified v i rus harvested 
from transfected cu ltures using the F IV antiserum 
from infected cats. The relative packaging 
efficiencies were calculated from ODs of 20 
cycles. 
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Hygro cassette in the background of pcDNA3 ( Fig, IV,S ,  panel A) ,  Semi-quantitative 
RT-P R analysis of  the transfer vector RNAs packaged in the virions showed that 
AG02 1 with the 3 '  LTR was packaged with a 3-fold enhanced efficiency than AG029 
( Fig, IV,  , panel B) confinning the results obtained earl ier ( Fig, IVA) ,  Once again, 
AG02 1 and AG029 were expressed efficiently in the cytoplasm ( Fig, IV .S ,  panel C), cells 
were fractionated appropriately ( Fig, IV ,S ,  panel D), and simi lar levels of viri ons were 
produced in the transfected cul tures ( Fig, IV,S , panel B) ,  
The U3 portioll of the L TR also contains packaging determillants. To detemrine 
whether the increase in the packaging efficiency was due to the presence of the U3 
element we constructed AGOS I that expressed the entire LTR U3IR1US,  from the CMV 
promoter and compared the packaging efficiency of its RNA with that from AG029, the 
vector that expressed the RlUS  region only form the C MV promoter ( Fig, IV ,6,  panels A 
& B) ,  As sho\\'TI, the addition of U3 increased the packaging effic iency of AG029 by 2 
folds, reveal ing that the U3 region of the L TR also contributes to packaging of the FlV 
RNA contrary to publ ished findings ( Kemler et  a I . ,  2004) ,  
The COil text of the L TR determilles its reLative cOlltribution to FI V RNA packaging. 
Since the FIV LTR when present at the 3 end is transcribed unt i l  the poly A signal in the 
R region, we determined whether there was any di fference when only U3/partial R 
sequences were present ( up to the poly A signal at nt 253  in the LTR) in the transfer 
vector RNAs expressed from the CMV promoter (AGOS3 )  versus U3/complete R (nt 28 1 )  
(AGOS2) ,  or the entire U31R1US (up to nt 357)  (AGOS 1 )  and compared the packaging of 
these transcripts with those expressed from AG00 1 ( Fig,  IV.7 ,  panel A) ,  AGOO I 
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Figure I V.5. The 3'  L TR increases the packagi ng efficiency of F I  RNA. A) 
chematic representation of the transfer vectors with and without the 3 '  L TR. B) 
eml -quantltahve RT-PCR of v iral cDNAs ampl ified using OTR5 1 6  (R) and 
OTR459 (end of US) primers for 20, 25 and 30 rounds of PCR and probed using 
the RlU5 probe. The panel below shows the 0 ase-treated v ira l  RNA which was 
ampl ified using plasmid specific primer OTR366/367 (hygro primer). +C, plasmid 
as a posit ive control . The bottom panel shows the Western blot analys is  of 
equi alent amounts of the remaining one fourth purified v i rus harvested from 
transfected cultures using the F l Y  anti serum from infected cats. C) Control for 
nucleocytoplasmic fractionation technique. The upper panel i s  the RT-PCR on 
cytoplasmic RNA for spl iced act in  which shou ld be present i n  both the nuclear and 
cytoplasmiC fractions, whi le the bottom panel is a multip lex RT-PCR for unspl iced 
�-actin mRNA that should be exc lusively nuclear and 1 8S ribosomal RNA as a 
contTol for the presence of cDNA. D) RT-PCR of cytop lasmic cD A ampl ified 
using OTR5 1 6  (R) and OTR459 (end of US)  primers. The bottom panel shows the 
o lase-treated cytoplasmic RNA, which was ampl ified using plasmid specific  
pnmer OTR366/367 (hygro primer). The relative packaging efficiencies were 
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Figu re IV.6. The U3 part of the 3' LTR in particular increases the packaging efficiency 
of flY RNA.  A) Schemat ic representation of the transfer vectors either with RlU5 or 
U3,RJ 5 in the heterologous context . B) Semi-quantitative RT-PCR of v i ral cDNAs 
amplified using OTRS 1 6  ( R) and OTR459 (end of U5 )  for 20, 25 and 30 rounds of PCR 
and probed using the RlU5 probe. The panel below shows the DNase-treated v i ral RNA 
which was ampli fied using plasmid specific primer OTR366/367 (hygro primer). +C, 
p lasmid as a posit ive contro l .  The bottom panel shows Western blot analys is of 
equivalent amounts of the remain ing one fourth purified v i rus harvested from transfected 
cultures using the F IV  anti serum from infected cats. C) Control for nucleocytoplasmic 
fractionation technique. The upper panel is the RT-PCR on cytoplasmic RNA for spl iced 
actin  which should  be present in both the nuclear and cytoplasmic  fractions, whi le the 
bottom panel is a multiplex RT-PCR for unspl iced �-acti n  mRNA that should be 
exclusively nuclear and I SS ribosomal RNA as a control for the presence of cDNA. D) 
RT-PCR of cytoplasmic cDNAs ampl i fied using OTR660 (R) and OTR60 1 (SY40). The 
bottom panel sho\ s the DNase-treated cytoplasmic RNA, which was ampl i fied using 
p lasmid spec ific primer OTR366/367 (hygro primer). The relat i ve packaging 
efficiencies were calculated from the average of both 25 and 20 cycles ODs using 
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Figu re IY.7. The context of the LTR determines the relative contribution to FlV 
RNA packaging. A) Schematic representat ion of the transfer vectors with 
U3fRlU5 or U3/R or U3/partial R, or the 3 '  LTR in the 3 '  context. B) Semi­
quantitat ive RT-PCR of v i ral cD As ampl ified using OTR627 (beginn ing of 
U3) and OTRS I 7  (end of U3) primers for 20, 25 and 30 rounds of PCR and 
probed using the U3 probe. The panel below shows the 0 ase-treated viral 
R.; A which \ as ampl ified using plasmid spec ific primer OTR366/367 (hygro 
primer). +C, plasmid as a posit ive control .  The bottom panel shows the Western 
blot analysis of equivalent amounts of the remaining one fourth purified v i rus 
harvested from transfected cultures using the FrY antiserum from infected cats. 
C) Control for nucleocytoplasmic fractionation technique. The upper panel is the 
RT-PCR on cytoplasmic RNA for spl iced act in which should be present in both 
the nuclear and cytoplasmic fractions, whi le the bottom panel is a mult iplex RT­
PCR for unspl iced p-acti n  mRNA that should be exclusively nuclear and 1 8S 
ribosomal RNA as a control for the presence of cD A .  D) RT-PCR of  
cytoplasmic cD As ampl i  fied using OTR627 (beginning of U3) and OTR5 1 7  
(end of U3)  primers. The bottom panel shows the DNase-treated cytoplasmic 
RNA, which was ampl i fied using plasmid specific primer OTR366/367 (hygro 
primer). The relative packaging efficiencies were calculated from the average of 
20 and 25 cyc le ODs using d ifferent exposures. 
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temlination, and therefore should contain only the U3 and partial R sequences at the 3 '  
end of the transcript ( Fig. J .7 ,  panel A). Test o[ these constructs in our packaging assay 
revealed that AG05 1 AG052, and AG053 were packaged within 2-folds of each other in 
the FI viral partic les suggest ing that a l l  the necessary packaging detenninants were 
present in the UJ partial R region. Interestingly, the transcripts from AGOO l were 
packaged with nearly I O-fold lower efficiency than AG053 ( Fig. IV .7, panel B) .  This 
was not because the transcripts were not produced appropriate ly from the SV40 promoter 
in AG00 1 since simi lar Ie els of mRNAs were expressed in the cytoplasm of the 
transfected cel ls ( Fig. IV.7 ,  panel D). Once again, the amount of virions produced were 
s imi lar in these cul tures, the RNA samples were DNase-treated appropriately, and the 
fract ionation technique was rel i able ( Fig. IV.7 ,  panels B-D) .  
To confirm these findings independent ly, we compared the amount of  virion RNA 
packaged from transfer vectors AG00 1 and AG053 using a different primer pair. Once 
again, a 20-fold difference in packaging efficiency was observed ( Fig. IV .8 ,  panel A). 
Additionally, we compared the amount of  virion RNA packaged from transfer vectors 
AG00 1 with AG02 1 .  AG02 1 is similar to AGOO ! in that it  uses the 3 '  LTR for transcript 
temlination, but uses the CMV promoter to express the RNA, thus by-passing the need 
for the SV promoter. Test of these constructs revealed that both vectors were packaged 
\\'ithin 3-folds of each other an effect attributed to the presence of R!U5 sequences in 
AG02 1 ( Fig .  IV.8 ,  panel B) .  These results c learly show that the F IV LTR when expressed 
in the 3 context is less efficient in enhanc ing packaging than when present at the 5 '  end. 
The U3/R folds differently when at the 3 '  end versus when at the 5 '  end. To detemune 
why the packaging efflciency of U3/R determinants di ffered when expressed from the 5 '  
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Figu re I V .8. The 5 '  context of the L TR has better packaging potential than the 3 '  
context. ) Semi -quanti tat ive RT-PCR of v iral cDN As ampl i fied using OTR627 
(beginning of U3) and OTR5 1 7  (end of U3) primers for 20, 25 and 30 rounds of PCR 
and probed using the U3 probe. B) Semi -quantitative RT-PCR of v i ra l  cDNAs 
amplified usi ng OTR627 (begi nning of U3) and OTR5 1 7  (end of U3) primers for 20, 
25 and 30 rounds of PCR and probed llsing the U3 probe. The relative packaging 
efficIencies were calculated from the ODs obtained from 25 and 20 cycles. 
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versus the 3 '  end the U3/R1U5 was folded in the 5 '  and 3 '  contexts. At the 5 '  end, these 
sequences were expressed [rom the CMV promoter, whi le at the 3 '  end, the FlV L TR 
was c loned along with � 1 20 bp o[ the upstream adjacent F lY  sequences that contain 
coding sequences [or the 3 '  end o[ env and rev ex on 2. As shown in Fig. IV.9, the 
U3 RlU5 folded into four stem loop structures that were conserved whether U31R1U5 or 
U3 R were expressed from the 5 '  end. However, only the last three of these stem loops 
were conserved in 3/partial R. Upon comparison of  these structures with those from 
AGOO I (containing sequences 1 20 bp upstream of 3 '  LTR, entire U3, and partial R), only 
the middle two of  the four stem loops were conserved. Since RNA from AG00 1 was the 
least efficient of  all in terms of packaging these analyses suggest that the last stem loop 
either contains the major U3 packaging detenninant or that the loss of this stem loop 
affects the stabi l ity of  the other stem loops in the U3/part ial R. 
The packagi n g  dete r mi n a n ts w i t h i n  the UTR a n d  gag consti t u te t h e  core p ackaging 
deter mi n a n ts of F I V. 
Final ly, using our already constructed vectors we asked the question as to which of the 
regions of Fl  contains the primary packaging determinant, RlU 5  at the 5 '  end, 1 50 bp 
UTRI I OO bp gag, or the 3 '  L TR. S ince we were l i rnited by the primer pairs we could use 
for a simultaneous analysis of the constructs vectors were chosen that contained RlU5 in 
common ( Fig. IV.  I 0 ,  panel A) .  Semi-quantitative RT-PCR analysis of  these constructs 
revealed that RlU5 on its own was a weak packaging signal . The packaging efficiency 
increased by - 4-folds in the presence of the 3' LTR, as observed before. With the 
addition of the 90 bp UTRI I 00 bp gag, the packaging efficiency increased further and 
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Figure IV.9. foldmg potential of the f l Y  transfer vector RNAs expressing the U3, R, or U5 
elements in either the 5' or 3' context. The ovals represent the conserved stem loop structures. 
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Figu re IY. I O. The major core determinants of F l Y  RNA packaging l ie within 
1 50 bp of the 5'  UTR and 1 00 bp of gag whi le RlU5 and 3 p lay a minor role 
in F IV RNA packaging. A) Schematic representat ion of the vectors tested. B) 
Semi -quantitat ive RT-PCR of v i ral cD As ampl i fied using OTR660 ( R) and 
OTR459 (end of US)  primers for 20, 25 and 30 rounds of PCR and probed 
using the RJU5 probe. The relative packaging effic iencies were calculated 
from the ODs of20 cycles. 
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each incremental increase in the UTR kept increasing the packaging efficiency ti l l  1 50 bp 
were reached when rna imum packaging efficiency was observed - 1 2-fold over that 
observed for the vector with RlU5 only ( Fig. IY. 1 0, panel B). These data indicate that 
the TR.Jgag contain the primary packaging determinants of FlV and not RlU5, as 
uggested by Kemler et a I . ,  2002 . 
This conclusion is further supported by our earlier genetic and structural analysis 
of the LTR and 5 '  UTR region presented in Chapter I I I .  These analyses had re ealed that 
d spite the presence of RlU5 region in all the test vectors, packaging of the vector RNAs 
,vith 90 bp UTR was great ly compromised compared to those containing 1 20 and 1 50 bp 
UTR. Al l  these vector RNAs, ilTespective of whether they were packaged efficientl y  or 
inefficiently, maintained the stem loop structure, SL 1 ,  stably in the US region of the 
RNA, whi le only the RNAs that partial ly restored the folding of stem loop 2 SL2,  
present in the 5 '  UTR were able to  enhance the packaging efficiency of their RNAs. 
Several reasons may explain the discrepancies in the observations of the two 
studies inc luding our observation that the 3 '  L TR also contains FlV packaging 
detenninants rel ated to different construct design or v ira l  strains. The Kemler study, for 
example used ful l -length genomic constructs, whi le  our studies were conducted using 
non-viral heterologous or sUbgenomic constructs that lacked most of the sequences 
encoding for the structural genes . Presence of negative inhibitory elements within 
structural genes such as gag, pol, and env have been shown to affect expression of 
unspl iced mRNAs (transport, stabi l i ty, and translatab i l i ty) and hence could theoretical ly  
affect  the subsequent incorporation of the unspliced mRNA into virions ( reviewed in  
Cul len, 2003) .  Vector design i tsel f can  sometimes pose problems such as  those observed 
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by Poeschl a and col leagues who reported that addition of gag sequences beyond nt 3 1 1 
negatively impacted the abi l i ty of such transfer ector RNAs to be packaged into virions 
possibly related to the presence of the highly structured RRE in their vectors ( poeschla et 
a t . ,  1 99 a) .  Final ly  it  seems that Kemler et at .  (2002 ) used the Petaluma strain for their 
anal_ s is which is  what we used as wel l ;  however, their UTR is about 273 bp in length 
compared to 270 bp in our case, suggesting that perhaps a di fferent molecular clone of 
F rv Petal uma was analyzed by them. 
Together with the results presented in Chapter I I I , our studies reveal that F lV 
R A packaging detemunants are as complex as those of other lentiviruses, reflecting the 
multidimensional nature of how genomic RNAs are packaged by the assembl ing vilion. 
Tlus  requires not only recognition of  the RNA structural features by the Gag polyproteins 
to distinguish between sub-genonUc and genomic mRNAs but a lso issues related to RNA 
din1erization. Sequences responsible for retroviral RNA dimerization co-map to regions 
simi lar to RNA packaging determinants and despite intensive investigations it is sti l l  not 
c lear whether RNA packaging precedes retroviral RNA dimerization or comes l ater 





This thesis was UndeJ1aken to fine map the sequences required for efficient FrV 
RN packaging into the viral particles. Using our previously  publ ished results, we 
embarked upon a two-pronged strategy to address this quest ion. Our previous results 
reyealed that the F I  packaging determinants consisted of two core elements, one 
encompassing � 1 20 bp of 5' UTR whi le  the other about the first 1 00 bp of gag 
(Browning et aI . ,  2003 a & b).  To fine tune our mapping, we conducted an incremental 
deletion analysis of the intervening sequences between the two core e lements, or 
substi tuted the deleted region with heterologous sequences of same length to determine 
whether the intervening region itself p layed a role  in FIV RNA packaging, or simply 
acted to maintain the distance between the two core elements (Chapter I I I ) . 
We went on to dissect the role of the LTR elements towards packaging since it 
was suggested that L TR elements may have a key role to play in packaging, but only 
when present at the 5' end of the viral RNA ( Kemler et al . ,  2002) .  Since our earl ier 
constructs maintained most of  the 5' LTR and all of the 3 LTR, we constructed another 
series of vectors that tested the effects of the U3,  R, and US sequences on F LY RNA 
packaging in both the 5' and 3 '  contexts (Chapter IV) .  
Our incremental deletion analysis of the region intervening the two core 
packaging determinants confirmed the earl ier observations that the major determinants of 
F IV RNA packaging l ie within two discontinuous regions, the first 1 50 bp of  5 '  UTR and 
the first 1 00 bp of gag (Chapter I I I ) . Furthermore, we demonstrated that the sequences in 
behveen the two core packaging determinants are dispensable  for packaging; neither do 
they affect packaging direct ly, nor do they act as spacers to maintain any structural 
features of the region (Chapter I I I ) . In terms of the LTR elements, our data revealed that 
1 00 
both the 5 '  R 5 region and the 3 '  L TR contribute to F lY RNA packaging and to a 
simj lar extent (Chapter IV) .  The U3 region was a lso shown to affect packaging 
specifical ly (Chapter I ) .  A comparative analysis of a l l  the regions involved in 
packaging revealed that the first 1 50 bp UTR in combination with the first 1 00 bp of gag 
had the strongest in fluence on packaging, makjng them the core packaging determinants 
(Chapter IV) .  
Since reh'oviral RNA packaging determinants are thought to  fold into rugher order 
structures, we folded the RNA regions found to be important for packaging using the 
RNA folding algorithm, RNAstructure ( Mathews et a I . ,  1 999). Analysis of the predicted 
structures revealed that the 5 '  end of the F IV genomic RNA folded into se eral stable 
stem loops a situation s inlilar to H IV, SIV and M P MV ( Fig. V . l & Fig .  1 . 7) .  Two stem 
loop structures were observed in the RJU5 region ( label led "R" and "RJU5" in Fig. V . I ), 
but only transient ly, suggesting that more than l ikely they are not involved in RNA 
packaging since they are unstable  to begin with. Sinli larly a structure with a huge loop 
was identified within the first 1 00 bp of gag ( labeled "AUG Gag"), but also not 
consistently, suggesting that the gag region probably does not function at a structural 
level either (see Chapter I I I ) .  In between these unstable  structures, we observed four 
stab le  stem loops designated SL 1 -4 ( Fig. V. I ) . S L 1  was found within US, a region 
involved in packaging; however, we feel that this stem loop is not significantly involved 
in packaging since it was present in vector RNAs that were packaged poorly 
(AG002/AG0 1 3 ,  Chapter I I I ) .  SL2,  found within the first - 1 80 bp of the UTR, was the 
most consistently formed stem loop structure found to be associated with enhanced 
packaging (Chapter I I I ) .  Even the emergence of the first two loops of SL2 were found to 
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Figu re . 1 .  The predicted secondary RNA structure of the 5 '  end of the F lY RNA from the cap 
site (nt I )  to the first 74 bp of gag (nt 484) .  The major cis-acting sequences of the v irus are 
highl ighted by the gray shading such as the primer bind ing site (PBS), major spl ice donor (mSD), 
and the gag in i t iation codon . The structural features are l abeled according to the region of the v iral 
genome they exist in. The regions of stem loop (SL) 2 reformed in the presence of 1 20 and 1 50 bp 
UTR are shown by the brackets along the sides along with the mutat ions in SL2 introduced by 
Kemler et a l . ,  2002. 
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improve packaging sign i ficantly (AG003/AGO I 4) ,  whi le  2/3rds of  it ( found within 1 50 bp 
UTR) wa shown to restore packaging to nearly that of the "YJ ld type (AG004/AG0 1 5) .  
Thi s suggested that onl y part of  this stem loop plays a critical role in packaging. SL3 and 
4, on the other hand, were not found to correlate \ ith the functional packaging data 
( bapter I I I ) .  ince we did not carry a mutational analysis for any of these structures, we 
do not know whether they play a role in FIV RNA packaging at the structural level or at a 
primary sequence level . Kemler et a l .  (2002) mutated part of  S L2 highl ighted in Fig. 
V . I ;  however they observed no effect of the mutations on the packaging of these RNAs. 
Interestingly, the predicted structure of the mutated region looked completely different 
from ours and seemed to form a short stem loop of  its own . In combination with our 
folding predictions their mutational analysis suggests that ei ther their mutations did not 
rea l ly  perturb the structure of SL2 significantly, or the region encompassing the 
mutations is not directl y  involved in packaging ( i t  is away from the tip region of SL2 that 
seems l ike the important region).  
Together, the mutational and structural data from our study suggests that the two 
core F lV packaging determinants are probably  complementary and act together to 
enhance packaging. I t  is  our speculat ion that the first 1 50 bp of the UTR probably  
interacts at a structural level (perhaps along with the other packaging detemlinants within 
the LTR) with the Gag polyprotein whi le the first 1 00 bp in gag may act at a primary 
level and be involved more in the identification of the genomic mRNA from the 
multi tude of sUbgenornic rnRNAs that would lack this intronic region. This emerging 
scenario seems opposite to what we have observed in MPMV in terms of the contribution 
of the two elements to packaging (Schmidt et a1., 2003 ; Mustafa et a 1 . ,  2004) . Deletion 
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and site directed mutagenesis o[ the first four stem loops of  the M PMV 5 UTR region 
has ident i fied sequences encompassing SL l as the core detelminant of MPMV RNA 
packaging, but at the primary sequence level , wh i le the first �1 30 bp of gag seem to fold 
into 3 hort stem loops that may be responsible for providing the structural interaction(s) 
needed for specific incorporation of the genomic RNA into the virus part ic le .  The 
requirement of the gag stem loops to efficient packaging remains to be genetical ly 
confim1ed. 
The region between the 5 '  mSD and the start of  the gag (which is around 20 bp) is 
not critical for FlY RNA packaging since a deletion in this region had minimal effects on 
the packaging efficiency. ( Browning et a l . ,  2003a ; Kemler et a I . ,  2002) .  However, in the 
absence of gag, we have shown that this region becomes clitical for F IV RNA packaging 
since deletion of thi s  region results in the inabi l ity of the core packaging determinant 
present within the 1 50 bp of the 5' UTR to function as a packaging signal ( Browning et 
a l . ,  2003a) .  Thus, despite the absence of core packaging sequences in between the SD and 
Gag ATG, F IV RNAs lacking this region are packaged highly inefficiently in the absence 
of gag, further suggesting that gag sequences have a stab i l izing role  on the packaging 
potential of F lY  vector RNAs. 
The involvement of gag sequences as part of packaging determinants of viruses 
where the core determinant seems to be upstream of the mSD ( and hence part of al l  
mRNAs) provides a convenient way of differentiating between spl iced and unspl iced 
mRNAs. TIus may be true not only for F lY, but also for S IV and MPMY (Strappe at al . ,  
2003 ; Schmidt e t  aL ,  2003) .  However, in  the case of H IV-2 which has  i t s  packaging 
determinant upstream of the mSD also, there does not seem to be any gag sequence 
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invol ement at the packaging signal Ie el .  H IV -2 has solved the problem of  genomic 
mR A recognition by using a unique sorting mechanism where only those mRNAs 
capable of translating Gag in cis can be packaged into the virus partic le .  These mRNAs 
are captured by the co-translated Gag polyproteins v hi le being translated on polysomes 
in the cytoplasm ( Kaye and Lever, 1 999). Although no direct evidence is presented in 
this thesis, one may speculate that gag may be involved in a simi lar co-translational 
mechan ism for FI (and the same may be true for other retroviruses with their core 
packaging detenninants upstream of the mSD such as SIV and MPMV (Strappe et a1 . ,  
2003 ; Schmidt et a I . ,  2003» . 
As noted earl ier, Strappe et a l .  (2003 ) have proposed that it is not the position of 
the mSD relative to the core packaging detelminant that may be important for specific 
encapsidation of  genomic RNAs, rather the distance between the cap site and the core 
packaging determinants as it may affect the competition between translation and 
encapsidation that the genomic RNAs must w1dergo . The distance between the core 
packaging s ignal relative to the cap is 300-400 bp in S IV, H IV- l ,  and H IV-2. In 
comparison, this distance seems to be much shorter in  FlV with only � 1 50 bp in between 
the cap site and the start of the core packaging determinant. The sign ificance of this 
observation is  not c lear. Perhaps, in viruses where gag sequences are also part of the core 
packaging determinant such as FlV, this distance may not be that crit ical for genomic 
RNA recognition. A similar observation has been made in M PMV where the distance 
bet\veen the cap site and the primary packaging determinant is  only � 1 40 bp as wel l .  The 
core packaging determinant of M P MV resides within the fiTSt 30 bp downstream of the 
PBS,  but also requires the first - 1 00 bp of gag sequences and the l ast 23 bp of the 5 '  
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TR for efficient RNA packaging ( chrnidt et a1 . ,  2003 ; Mustafa et a l . ,  2004). 
In short, our results reveal that similar to other complex lentivimses, the F lY 
packaging signal is complex and multipartite, residing plimari ly within the first 1 50 bp of 
the 5'  UTR and the first 1 00 bp of  gag. However, other determinants of  packaging also 
seem to be present in the RJU5 region of the 5' LTR and the U3fR region of the 3' LTR. 
ince FI -based self-inactivating vectors (S IN) would be good candidates for human 
gene therapy, the di spersal of FIV RNA packaging detemrinants makes thi s task sl ightly 
tricky, especial ly the involvement of the R element in the 3 '  LTR. Several strategies are 
a ai lable for making S IN vectors that exploit steps of  reverse transcription to prevent 
generation of package able ector RNAs. These include the use of repeat sequences or 
splice sites to remove the packaging s ignal dming reverse transcription of  the vector 
RNA (summarized in Browning, 200 1 ) . We wi l l  have to use a combination of such 
strategies to develop effective FIV -based S IN vectors, including deletion of not only the 
core packaging determinants in the 5 '  UTR and gag, but also deletion of as much of the 
U3 region of 3 '  LTR as possible (permissible since the marker/therapeutic gene wil l  use 
an internal promoter and wi l l  not need the viral promoter for expression). The fact that 
we could delete major portions of the 5 '  UTR without affecting vector RNA propagation 
significantl y  (see Table I I I .  I ) suggests that such deletions should not be detrimental to the 
abi l i ty of the vector RNA to complete the reverse transcription and integration process. 
Our prediction is that the remaining packaging detemunants within the R region in the 3 '  
LTR i n  the presence of  minimal U 3  sequences should not b e  able to function as an 
effective packaging signal or wi l l  have highly reduced packaging potential ,  resulting in 
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